Form990
Click to see attachment
Department of the TreasuryInternal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)
MediumBullet Do not enter social security numbers on this form as it may be made public.
MediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2018
Open to Public Inspection
A For the 2019 calendar year, or tax year beginning 01-01-2018 , and ending 12-31-2018
BCheck if applicable:
CName of organization
PATH
 
 
Doing business as
 
 
Number and street (or P.O. box if mail is not delivered to street address)
2201 WESTLAKE AVENUE NO 200
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
SEATTLE, WA98121
D Employer identification number

91-1157127
E Telephone number

G Gross receipts $ 388,448,491
F Name and address of principal officer:
BRIAN NEVILLE
2201 WESTLAKE AVENUE NO 200
SEATTLE,WA98121
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.PATH.ORG
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:  
L Year of formation: 1981
M State of legal domicile: WA
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: SEE PART III, LINE 1.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 14
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 14
5 Total number of individuals employed in calendar year 2018 (Part V, line 2a) ...... 5 787
6 Total number of volunteers (estimate if necessary) ............. 6 0
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, line 34 ......... 7b 547,406
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 347,844,394 305,315,221
9 Program service revenue (Part VIII, line 2g) ......... 41,949 1,500
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 2,168,657 3,037,130
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 5,225,302 980,560
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12) 355,280,302 309,334,411
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 66,754,537 62,762,146
14 Benefits paid to or for members (Part IX, column (A), line 4)..... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 136,040,867 139,545,675
16a Professional fundraising fees (Part IX, column (A), line 11e) ..... 0 0
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet3,186,635    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 126,837,131 110,458,648
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 329,632,535 312,766,469
19 Revenue less expenses. Subtract line 18 from line 12....... 25,647,767 -3,432,058
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 467,947,698 237,501,233
21 Total liabilities (Part X, line 26)............. 50,797,492 202,931,874
22 Net assets or fund balances. Subtract line 21 from line 20..... 417,150,206 34,569,359
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet

Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2018)
Form 990 (2018)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III..............
1
Briefly describe the organization’s mission: PATH'S MISSION IS TO ADVANCE HEALTH EQUITY THROUGH INNOVATION AND PARTNERSHIPS. (CONTINUED ON SCHEDULE O)
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? .....................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ...........................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 128,263,294 including grants of $ 15,311,912 ) (Revenue $ 1,500 )
GLOBAL HEALTH PROGRAMS: PATH'S GLOBAL HEALTH PROGRAMS DIVISION BRINGS TOGETHER OUR SIGNIFICANT COUNTRY EXPERIENCE AND DEEP TECHNICAL EXPERTISE TO FACILITATE THE ORGANIZATION'S ABILITY TO ACHIEVE IMPACT THROUGH INNOVATIVE APPROACHES AND SOLUTIONS. THIS DIVISION MANAGES PATH'S PRESENCE IN COUNTRY OFFICES AND IS RESPONSIBLE FOR PATH'S SCIENTIFIC EXPERTISE IN MALARIA AND NEGLECTED TROPICAL DISEASES; HIV AND TUBERCULOSIS; MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; SEXUAL AND REPRODUCTIVE HEALTH; NONCOMMUNICABLE DISEASES; HEALTH SYSTEMS INNOVATION AND DELIVERY; AND DIGITAL HEALTH SOLUTIONS.(CONTINUED ON SCHEDULE O)MALARIA AND NEGLECTED TROPICAL DISEASESPATH PARTNERS WITH GOVERNMENTS, THE PRIVATE SECTOR, AND FUNDERS ACROSS THE GLOBE TO BRING THE WORLD CLOSER TO MALARIA ERADICATION. MORE THAN 200 PATH STAFF MEMBERS WORK ON MALARIA IN MORE THAN 30 COUNTRIES. OUR STRATEGY INCLUDES OPTIMIZING THE DELIVERY OF CURRENT TOOLS AND APPROACHES TO ENSURE THEY REACH THE PEOPLE WHO NEED THEM, DEVELOPING NEW STRATEGIES FOR ELIMINATION, DEVELOPING NEXT-GENERATION TOOLS TO OVERCOME EMERGING CHALLENGES, AND CREATING INNOVATIVE PARTNERSHIPS AND FUNDING MODELS TO ENSURE THAT OUR PROGRAMS ARE SUSTAINABLE AND EFFECTIVE. APPROACHES PIONEERED BY PATH HAVE CONTRIBUTED TO REMARKABLE PROGRESS TOWARD CONTROLLING AND ELIMINATING MALARIA, WITH NEARLY 7 MILLION LIVES SAVED SINCE 2000.IN 2018, OUR MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROGRAM CONTINUED TO SUPPORT THE GOVERNMENTS OF ETHIOPIA, SENEGAL, AND ZAMBIA AS THEY STRIVE TO ACHIEVE THEIR MALARIA ELIMINATION GOALS. WE HELPED BY SCALING UP PREVENTION AND TREATMENT, EVALUATING SENSITIVE DIAGNOSTIC TOOLS, ESTABLISHING RAPID REPORTING SYSTEMS, AND SUPPORTING POPULATION-WIDE, DRUG-BASED STRATEGIES, SUCH AS MASS DRUG ADMINISTRATION. THROUGH OUR PROGRAM FOR THE ADVANCEMENT OF MALARIA OUTCOMES, PATH ASSISTED THE GOVERNMENT OF ZAMBIA IN REACHING ITS GOALS FOR ELIMINATING LOCAL MALARIA INFECTION AND DISEASE. THIS WORK FOCUSED ON BEDNETS, MALARIA IN PREGNANCY, SOCIAL BEHAVIOR CHANGE, CASE MANAGEMENT, SURVEILLANCE, AND MONITORING & EVALUATION. THE PROGRAM'S GEOGRAPHIC FOCUS IS ON PROVINCES WITH THE HIGHEST MALARIA PREVALENCE AMONG CHILDREN.PATH ALSO WORKED TO IMPROVE DATA FOR MALARIA CONTROL DECISION-MAKING AND SURVEILLANCE. IN ZAMBIA, FOR EXAMPLE, THE VISUALIZE NO MALARIA PROJECT-A GROUNDBREAKING PARTNERSHIP WITH A SEATTLE-BASED SOFTWARE COMPANY AND A COALITION OF OTHER TECHNOLOGY COMPANIES-CONTINUED TO EXPAND. THIS PROJECT EQUIPS HEALTH WORKERS AND OFFICIALS WITH REAL-TIME DATA VISUALIZATION TOOLS TO SEE WHERE MALARIA IS APPEARING SO THEY CAN DEPLOY RESOURCES TO HALT ITS SPREAD. IN WESTERN KENYA, PATH ASSESSED THE POTENTIAL CONTRIBUTION OF MALARIA TESTING DATA FROM PREGNANT WOMEN ATTENDING ANTENATAL CLINICS AS A MEANS TO BOLSTER SURVEILLANCE.IN 2018, PATH ALSO WORKED WITH THE WORLD HEALTH ORGANIZATION (WHO) AND OTHER PARTNERS TO PREPARE FOR PILOT IMPLEMENTATION OF THE RTS,S MALARIA VACCINE IN SELECTED AREAS OF GHANA, KENYA, AND MALAWI. VACCINATIONS ARE DUE TO BEGIN IN 2019. PATH CONTINUED TO DEVELOP AND EVALUATE NEW VECTOR-CONTROL TOOLS SUCH AS NEXT-GENERATION INDOOR RESIDUAL SPRAYING (IN PARTNERSHIP WITH THE INNOVATIVE VECTOR CONTROL CONSORTIUM, THE US PRESIDENT'S MALARIA INITIATIVE, ABT ASSOCIATES, AND THE GLOBAL FUND). THIS WORK IS GENERATING EVIDENCE TO SUPPORT TIMELY DECISION-MAKING AROUND THE ADOPTION OF NEW INSECTICIDES THAT ARE EFFECTIVE AGAINST PYRETHROID-RESISTANT MOSQUITOES. PATH ALSO LED EVALUATION AND DATA-FOR-DECISION-MAKING ACTIVITIES UNDER VECTORLINK, THE US AGENCY FOR INTERNATIONAL DEVELOPMENT'S (USAID'S) FLAGSHIP VECTOR-CONTROL PARTNERSHIP. IN ADDITION, WE DIRECTED EVIDENCE-GENERATION ACTIVITIES UNDER THE NEW NETS PROJECT, FUNDED BY UNITAID AND THE GLOBAL FUND, TO HELP SCALE UP ACCESS TO AND USE OF NEW LONG-LASTING INSECTICIDE-TREATED NETS.TO ADDRESS THE TWIN THREATS OF INSECTICIDE RESISTANCE AND OUTDOOR BITING BY MOSQUITOES, PATH CONTINUED THE DEVELOPMENT AND EVALUATION OF ATTRACTIVE TARGETED SUGAR BAITS, WHICH PRESENT A SUGAR MEAL FOR MOSQUITOES THAT IS LACED WITH AN INSECTICIDE. PATH ALSO SUPPORTED THE DEVELOPMENT OF A NEW, HIGHLY SENSITIVE RAPID DIAGNOSTIC TEST THAT OFFERS A GREATER THAN TENFOLD IMPROVEMENT IN DETECTION OF THE MOST COMMON MALARIA PARASITE. FINALLY, WE ADVANCED WORK ON A POINT-OF-CARE DIAGNOSTIC TEST FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, A CONDITION THAT CAN COMPLICATE MALARIA TREATMENT.IN PATH'S EFFORTS TO FIGHT NEGLECTED TROPICAL DISEASES, OUR WORK INCLUDES DEFINING PRODUCT NEEDS; DEVELOPING TARGET PRODUCT PROFILES; ENGAGING WITH STAKEHOLDERS; CONDUCTING LABORATORY AND FIELD TESTS AND EVALUATIONS; TRANSFERRING TECHNOLOGY AND SECURING MANUFACTURING, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTS; COMMERCIALIZING PRODUCTS AND COLLATERAL; AND SUPPORTING PRODUCT LAUNCH. MUCH OF THIS WORK IS ACCOMPLISHED VIA PATH'S TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION DIVISION.HIV AND TUBERCULOSISPATH CONTINUED TO CONTRIBUTE TO HIV PREVENTION AND EPIDEMIC CONTROL IN 2018 BY FOCUSING PROGRAMMING ON THE KEY AND HIGH-PRIORITY POPULATIONS OF ADOLESCENT GIRLS AND YOUNG WOMEN, PEOPLE WITH BOTH HIV AND TUBERCULOSIS (TB), SEX WORKERS AND THEIR CLIENTS, MEN WHO HAVE SEX WITH MEN, PEOPLE WHO INJECT DRUGS, AND TRANSGENDER INDIVIDUALS. WE ADVANCED PROGRAMMING ACROSS MULTIPLE TECHNOLOGY AND SERVICE DELIVERY PLATFORMS-FROM DEVICES, TOOLS, AND DIAGNOSTICS TO SERVICE DELIVERY INNOVATIONS AND ADVOCACY. PATH'S WORK IN DIAGNOSTICS FOCUSED ON FILLING GAPS IN FOUR CRITICAL AREAS: SELF-TESTING, EARLY INFANT DIAGNOSIS, TB DETECTION AMONG PEOPLE LIVING WITH HIV, AND VIRAL LOAD DETECTION. WE FOCUSED ON UNDERSTANDING THE BARRIERS THAT RESTRICT ACCESS TO HIGH-QUALITY DIAGNOSTICS AND ADVANCING NEW PRODUCTS TO OVERCOME THESE OBSTACLES. TO INFORM DESIGN AND DELIVERY OF NEXT-GENERATION HIV SELF-TESTS, PATH EMPLOYED USER-CENTERED DESIGN METHODOLOGIES TO CREATE USER PERSONAS REPRESENTING KEY POPULATIONS. PATH ALSO WORKED TO EVALUATE AND ADVANCE DEVICES TO PROVIDE LONG-TERM ANTIRETROVIRAL DELIVERY FOR PRE-EXPOSURE PROPHYLAXIS (PREP) AND HIV TREATMENT. THESE DEVICES INCLUDE MICROARRAY PATCHES FOR TRANSDERMAL DELIVERY AND AN APPLICATOR TO SUBCUTANEOUSLY INSERT BIODEGRADABLE IMPLANTS. WE ALSO WORKED ON A PEDIATRIC-FRIENDLY DOSAGE FORM OF ANTIRETROVIRAL DRUGS, USING OUR FAST-DISSOLVING TABLET TECHNOLOGY.THROUGH THE AIDS, POPULATION, AND HEALTH INTEGRATED ASSISTANCE PROGRAM PLUS (APHIAPLUS PROJECT), PATH HELPED TO INTEGRATE HEALTH SERVICES IN WESTERN KENYA AND ENABLE MORE PEOPLE TO ACCESS A GREATER SPECTRUM OF SERVICES. SINCE 2011, THE PATH-LED TEAM HAS BUILT THE CAPACITY OF HEALTH CARE WORKERS AND FACILITIES TO DELIVER HIGH-QUALITY SERVICES FOR HIV, TB, SEXUAL AND REPRODUCTIVE HEALTH, AND ADOLESCENT HEALTH; STRENGTHENED LINKAGES BETWEEN HEALTH FACILITIES AND COMMUNITIES TO EXPEDITE ACCESS TO HIV CARE AND TREATMENT; ESTABLISHED COMMUNITY SUPPORT SYSTEMS FOR PEOPLE LIVING WITH HIV AND THEIR FAMILIES; AND EMPOWERED AND MOBILIZED COMMUNITIES AROUND HIV PREVENTION AND OUTREACH.IN 2018, PATH TRANSITIONED HIV ACTIVITIES IN KENYA'S FORMER NYANZA PROVINCE TO USAID'S PATH-LED AFYA ZIWANI PROJECT, WHILE CONTINUING HIV AND TB SERVICE DELIVERY IN THE FORMER WESTERN PROVINCE THROUGH APHIAPLUS. WITH FUNDING FROM THE US PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF DREAMS INITIATIVE, APHIAPLUS AND THE AFYA ZIWANI PROJECT INTENSIFIED EFFORTS TO REACH MORE THAN 77,500 ADOLESCENT GIRLS AND YOUNG WOMEN IN KENYA WITH INTERVENTIONS TO REDUCE THEIR VULNERABILITY TO HIV AND IMPROVE THEIR ACCESS TO SERVICES. THIS WORK INCLUDED THE CREATION OF MORE THAN 200 SAFE SPACES AND IMPROVED ACCESS TO YOUTH-FRIENDLY FAMILY PLANNING, HIV, AND GENDER-BASED VIOLENCE SERVICES. IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), PATH CONTINUED TO LEAD USAID-FUNDED EFFORTS TO IMPROVE HIV/AIDS SERVICES. IN 2018, THIS WORK FOCUSED ON TWO HIGH-PREVALENCE PROVINCES UNDER THE INTEGRATED HIV/AIDS PROJECT IN HAUT-KATANGA AND LUALABA. PATH PROVIDED TECHNICAL ASSISTANCE TO 162 HEALTH FACILITIES, 18 HEALTH ZONES, AND 5 NONGOVERNMENTAL ORGANIZATIONS TO INCREASE TARGETED TESTING EFFORTS, ENROLL ALL IDENTIFIED HIV-POSITIVE INDIVIDUALS ON TREATMENT, SCALE UP VIRAL LOAD TESTING, AND ROLL OUT DIFFERENTIATED CARE MODELS TO IMPROVE RETENTION IN TREATMENT. AT THE END OF DECEMBER 2018, PATH WAS SUPPORTING MORE THAN 33,000 INDIVIDUALS IN THE DRC ON ANTIRETROVIRAL THERAPY.
4b (Code:   ) (Expenses $ 88,257,285 including grants of $ 37,275,906 ) (Revenue $   )
ESSENTIAL MEDICINES: PATH'S ESSENTIAL MEDICINES DIVISION DEVELOPS AND DELIVERS LIFESAVING VACCINES AND DRUGS FOR WOMEN, CHILDREN, AND COMMUNITIES AROUND THE GLOBE.(CONTINUED ON SCHEDULE O)CENTER FOR VACCINE INNOVATION AND ACCESSPATH'S CENTER FOR VACCINE INNOVATION AND ACCESS (CVIA) ALIGNS EXPERTISE ACROSS EVERY STAGE OF VACCINE RESEARCH, DEVELOPMENT, AND INTRODUCTION TO MAKE VACCINES GLOBALLY AVAILABLE TO MORE COMMUNITIES, PARTICULARLY IN LOW- AND MIDDLE-INCOME COUNTRIES. OUR PORTFOLIO INCLUDES MORE THAN TWO DOZEN VACCINE PRODUCTS IN DEVELOPMENT OR ALREADY IN USE, WITH AN EMPHASIS ON THE LEADING INFECTIOUS CAUSES OF CHILD DEATHS AND DISEASES WORLDWIDE.FOR EXAMPLE, IN 2018 WE CONTINUED TO PARTNER WITH COUNTRIES TO EXPAND COVERAGE OF JAPANESE ENCEPHALITIS (JE) VACCINE, WHICH PATH HELPED SHEPHERD THROUGH THE GLOBAL REGULATORY PROCESS AND SCALE UP. WITH SUPPORT FROM PATH, THE GOVERNMENT OF INDONESIA LAUNCHED JE VACCINATION CAMPAIGNS IN THE PROVINCE OF BALI. PATH ALSO PROVIDED TECHNICAL ASSISTANCE IN THE LEAD-UP TO JE VACCINATION CAMPAIGNS IN SELECT, HIGH-RISK REGIONS IN THE PHILIPPINES.IN 2018, WE CONTINUED A PHASE 2 STUDY OF A POLYVALENT MENINGOCOCCAL MENINGITIS VACCINE IN YOUNG CHILDREN IN MALI. THE VACCINE, DEVELOPED BY SERUM INSTITUTE OF INDIA PVT. LTD., BUILDS ON THE SUCCESS OF MENAFRIVAC, A VACCINE AGAINST MENINGOCOCCAL MENINGITIS SEROGROUP A THAT WAS LICENSED AND INTRODUCED IN 2010. THE POLYVALENT VACCINE TARGETS SEROGROUPS A, C, W, X, AND Y. THE VACCINE IS DESIGNED FOR USE IN THE AFRICAN "MENINGITIS BELT" REGION AND WILL BE THE FIRST VACCINE TO TARGET SEROGROUP X. TO PREVENT MALARIA, PATH IS ACCELERATING THE DEVELOPMENT OF A WIDE VARIETY OF MALARIA VACCINE CANDIDATES AND APPROACHES. IN 2018, PATH CONTINUED TO WORK WITH WHO AND OTHER PARTNERS TO PREPARE FOR PILOT IMPLEMENTATION OF THE RTS,S VACCINE IN SELECTED AREAS OF GHANA, KENYA, AND MALAWI. WITH PARTNERS, PATH CONTINUED TO ADVANCE RESEARCH INTO WHETHER REDUCING THE DOSE LEVEL OF RTS,S AND DELAYING THE ADMINISTRATION OF DOSES HAS THE POTENTIAL TO FURTHER AID MALARIA ELIMINATION EFFORTS BY STRETCHING LIMITED VACCINE SUPPLIES AND PROTECTING AS MANY PEOPLE AS POSSIBLE. FIELD TESTING OF THE DELAYED FRACTIONAL DOSE REGIMEN BEGAN AT A RESEARCH CENTER IN KENYA IN 2018.PATH'S DEFEAT DIARRHEAL DISEASE INITIATIVE, HOUSED WITHIN CVIA, CONTINUED ITS ONGOING WORK TO GENERATE INVESTMENTS IN ROTAVIRUS, ENTEROTOXIGENIC ESCHERICHIA COLI, AND SHIGELLA VACCINES WITHIN THE CONTEXT OF AN INTEGRATED PREVENTION AND TREATMENT APPROACH. THE PROJECT RECEIVED STANDALONE FUNDING IN LATE 2018 TO CONTINUE EDUCATING OUR TARGET AUDIENCES ON THE LIFELONG CONSEQUENCES OF REPEATED INFECTIONS. IN 2018, PATH ALSO HELPED INTRODUCE AND ADVANCE ACCESS TO CURRENTLY AVAILABLE ENTERIC VACCINES, INCLUDING THE NEWLY WHO-PREQUALIFIED ROTAVAC AND ROTASIIL ROTAVIRUS VACCINES AND TYPBAR-TCV TYPHOID CONJUGATE VACCINE. PATH LED AND/OR SUPPORTED ONGOING PHASE 4 CLINICAL TRIALS, CONDUCTED VACCINE IMPACT AND COST-EFFECTIVENESS ANALYSES, AND DISSEMINATED EVIDENCE THROUGH ADVOCACY AND COMMUNICATIONS TO INFORM COUNTRY DECISION-MAKING AROUND VACCINE INTRODUCTION AND PRODUCT SWITCHES.IN 2018, PATH CONTINUED TO SUPPORT SOUTH AFRICAN VACCINE MANUFACTURER THE BIOVAC INSTITUTE IN PRECLINICAL DEVELOPMENT OF A VACCINE AGAINST GROUP B STREPTOCOCCUS, THE LEADING CAUSE OF BACTERIAL SEPSIS AND MENINGITIS IN YOUNG INFANTS WORLDWIDE. THE INTENDED VACCINE POPULATION IS PREGNANT WOMEN-PART OF A STRATEGY THAT BOOSTS IMMUNITY AGAINST THE BACTERIUM AND TRANSFERS PROTECTIVE ANTIBODIES TO THE DEVELOPING BABY. ALSO IN 2018, PATH CONTINUED A PROJECT TO COORDINATE A CONSORTIUM OF NINE INDEPENDENT RESEARCH INSTITUTIONS TO COLLATE AND SYNTHESIZE EXISTING EVIDENCE AND EVALUATE NEW DATA ON THE POTENTIAL FOR SINGLE-DOSE HPV VACCINATION. ALTHOUGH MANY COUNTRIES HAVE INTRODUCED HPV VACCINES INTO THEIR NATIONAL IMMUNIZATION SCHEDULES, SOME LOW- AND LOWER-MIDDLE-INCOME COUNTRIES HAVE DELAYED INTRODUCTION BECAUSE OF FINANCIAL, LOGISTICAL, OR OTHER BARRIERS. FOR THESE COUNTRIES, A SINGLE-DOSE REGIMEN COULD ACCELERATE INTRODUCTION OF HPV VACCINES INTO NATIONAL IMMUNIZATION SCHEDULES.DRUG DEVELOPMENTTHROUGH OUR WORK ON DRUG DEVELOPMENT AND INTRODUCTION, PATH HELPS TO ENSURE THAT PEOPLE AROUND THE WORLD, ESPECIALLY CHILDREN LIVING IN LOW-RESOURCE SETTINGS, HAVE RELIABLE ACCESS TO LIFESAVING MEDICINES. WE WORK TO ADVANCE THE MOST PROMISING SOLUTIONS FOR A RANGE OF URGENT GLOBAL HEALTH CHALLENGES, INCLUDING ENTERIC AND DIARRHEAL DISEASES, NEGLECTED TROPICAL DISEASES, HIV/AIDS, AND MALARIA. DRAWING ON AN ENDURING COMMITMENT TO HEALTH EQUITY AND A UNIQUE PARTNERSHIP APPROACH THAT SPANS THE ACADEMIC, PRIVATE, NONPROFIT, AND GOVERNMENT SECTORS, OUR WORK OVERTURNS BARRIERS TO HEALTH AT EVERY STAGE OF DRUG DEVELOPMENT AND USE-FROM EARLY RESEARCH TO POLICY INTRODUCTION.IN 2018, IN COLLABORATION WITH PARTNERS, PATH CONTINUED TO ADVANCE A PORTFOLIO OF DRUG PROJECTS TO REDUCE THE GLOBAL BURDEN OF ENTERIC AND DIARRHEAL DISEASE AMONG YOUNG CHILDREN. FOR EXAMPLE, WE MADE SIGNIFICANT PROGRESS IN VALIDATING A NEW RESEARCH ASSESSMENT TOOL FOR ENVIRONMENTAL ENTERIC DYSFUNCTION (EED)-AN INTESTINAL DISORDER COMMON AMONG CHILDREN LIVING IN LOW-RESOURCE SETTINGS THAT IS ASSOCIATED WITH INCREASED RISK OF STUNTING, COGNITIVE DEFICITS, AND REDUCED RESPONSIVENESS TO ORAL VACCINES. THE TOOL IS DESIGNED TO MEASURE MULTIPLE BIOMARKERS, INCLUDING THOSE OF EED, SYSTEMIC INFLAMMATION, GROWTH HORMONE RESISTANCE, AND MICRONUTRIENTS, AND COULD BE AN ASSET FOR EED CLINICAL RESEARCH IN LOW-INCOME COUNTRIES. THE DIARRHEA INNOVATIONS GROUP (DIG), AN INTERNATIONAL NETWORK OF CHILD HEALTH STAKEHOLDERS HOUSED WITHIN AND CO-CHAIRED BY PATH, CONTINUED ITS WORK TO IMPROVE COLLABORATION FOR DIARRHEAL DISEASE RESEARCH AND ACCELERATE PROGRESS THROUGH PARTNERSHIPS. IN NOVEMBER 2018, DIG MEMBERS PETITIONED WHO TO INCLUDE CO-PACKAGED ORAL REHYDRATION SOLUTION (ORS) AND ZINC IN ITS MODEL LIST OF ESSENTIAL MEDICINES. JOINT ADMINISTRATION OF ORS AND ZINC HAS LONG BEEN RECOMMENDED FOR MANAGEMENT OF PEDIATRIC DIARRHEA, YET NO FORMAL GUIDANCE ON CO-PACKAGED ORS-ZINC EXISTED, AND THE NUMBER OF CHILDREN WITH DIARRHEA RECEIVING THE OPTIMAL TREATMENT REMAINS UNACCEPTABLY LOW AT LESS THAN 7 PERCENT. ONCE ADOPTED BY WHO, THIS GLOBAL POLICY CHANGE WILL HELP PRIORITIZE BOTH ORS AND ZINC AS THE DIARRHEA MANAGEMENT STANDARD AT THE NATIONAL LEVEL, ULTIMATELY IMPROVING COVERAGE AND SAVING LIVES.ALSO IN 2018, WE CONTINUED OUR WORK TO DEVELOP NEW THERAPEUTICS FOR CRYPTOSPORIDIUM, ONE OF THE KEY PATHOGENS RESPONSIBLE FOR DIARRHEAL MORBIDITY IN CHILDREN UNDER FIVE YEARS OF AGE. IN ADDITION, WE PREPARED FOR A STUDY TO TEST THE INVESTIGATIONAL NEW DRUG IOWH032 AS AN ANTISECRETORY THERAPY FOR THE TREATMENT OF CHOLERA.PARALLEL TO DRUG RESEARCH AND DEVELOPMENT, PATH CONTINUED OUR WORK TO ENSURE THAT ESSENTIAL MEDICINES ARE RELIABLY ACCESSIBLE TO THE PEOPLE WHO NEED THEM. OUR ACCESS TO ESSENTIAL MEDICINES INITIATIVE CARRIED OUT AN IN-DEPTH ANALYSIS OF THE WHO ESSENTIAL MEDICINES LISTS AND DEVELOPED A TOOL TO HELP IDENTIFY AND PRIORITIZE MEDICINES WITH SUBOPTIMAL ACCESS AND USE. THE TOOL IS DESIGNED TO HELP GLOBAL AND COUNTRY STAKEHOLDERS BETTER UNDERSTAND ACCESS GAPS AND THE HEALTH IMPACT POTENTIAL OF ESSENTIAL MEDICINES. THIS, IN TURN, CAN GUIDE DECISION-MAKING ON ACTIVITIES AND INVESTMENTS. IN 2018, WE INTRODUCED THE TOOL TO A NUMBER OF PARTNERS AND FUNDERS AND EXPLORED OPPORTUNITIES TO MAKE IT PUBLICLY AVAILABLE.
4c (Code:   ) (Expenses $ 26,496,089 including grants of $ 4,929,933 ) (Revenue $   )
TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION: PATH'S TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION DIVISION BEGAN THE YEAR AS TECHNOLOGY DEVELOPMENT AND INTRODUCTION (TDI). AS SUCH, IT WAS AN INTEGRATED GLOBAL PLATFORM FOR END-TO-END ADVANCEMENT OF HIGH-IMPACT DEVICES, TOOLS, DIAGNOSTICS, AND IN-COUNTRY "IMPACT LABS" THAT ADDRESS GLOBAL, REGIONAL, AND COUNTRY HEALTH NEEDS. IN JULY 2018, TDI GREW TO INCLUDE ADDITIONAL PROGRAMS-SUCH AS MARKET DYNAMICS, DIGITAL & DATA, AND MONITORING & EVALUATION-AND WAS RENAMED TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION (TAMI).(CONTINUED ON SCHEDULE O)DEVICES AND TOOLSTHE DEVICES AND TOOLS PROGRAM WITHIN TAMI IS PATH'S INNOVATIVE PRODUCT DEVELOPMENT ARM. THE PROGRAM WORKS WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS AROUND THE WORLD TO DEVELOP, TEST, REFINE, INTRODUCE, AND SCALE AFFORDABLE TECHNOLOGIES TO IMPROVE THE HEALTH OF PEOPLE IN LOW- AND MIDDLE-INCOME COUNTRIES.IN 2018, THE PROGRAM'S MILESTONES INCLUDED TRANSFERRING THE DESIGN OF THE BUBBLE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICE AND OXYGEN BLENDER TO A MANUFACTURER, BEGINNING FIELD EVALUATIONS FOR A FREEZE-SAFE VACCINE CARRIER IN NEPAL WITH A STUDY PARTNER, AND COMPLETING A PROGRAMMATIC AND HUMAN FACTORS EVALUATION OF THREE BLOW-FILL-SEAL VACCINE CONTAINERS IN AFRICA AND ASIA, AS WELL AS RECLASSIFICATION OF THE FEMALE CONDOM BY THE US FOOD & DRUG ADMINISTRATION FROM A CATEGORY III TO CATEGORY II MEDICAL DEVICE.STAFF PRODUCED 17 JOURNAL ARTICLES AND REPORTS ON RESEARCH FINDINGS, RANGING FROM ASSESSMENTS OF TECHNOLOGIES TO IMPROVE IMMUNIZATION TO EVALUATIONS OF NEONATAL RESUSCITATORS.DIAGNOSTICSPATH'S WORK TO ADVANCE ACCURATE DIAGNOSTIC TECHNOLOGIES THAT STRENGTHEN HEALTH EQUITY INCLUDES TOOLS TO DETECT AND MONITOR NEGLECTED TROPICAL DISEASES, MALARIA, HIV, POLIO, AND NONCOMMUNICABLE DISEASES.IN 2018, OUR PIONEERING WORK IN MALARIA DIAGNOSTICS INCLUDED DEVELOPING NEW TOOLS TO IMPROVE DETECTION OF THE MALARIA PARASITE AND TESTS TO GUIDE THE CLINICAL CARE OF PATIENTS. WITH OUR RESEARCH AND DEVELOPMENT PARTNERS, PATH ADVANCED SEVERAL POINT-OF-CARE TESTS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY, A CONDITION THAT CAN COMPLICATE TREATMENT OF PLASMODIUM VIVAX MALARIA. THIS INCLUDED COMPLETING FIELD-BASED STUDIES OF A QUANTITATIVE BIOSENSOR AND FACILITATING A COMMUNITY OF PRACTICE FOR GLOBAL RESEARCHERS WORKING TO ADVANCE G6PD DIAGNOSTICS. PATH DEVELOPED GEODX, A COMPUTER PROGRAM THAT ESTIMATES THE PLASMODIUM VIVAX BURDEN PER HEALTH FACILITY, THE TOTAL QUANTITY OF G6PD TESTS THAT WOULD BE REQUIRED PER COUNTRY, AND THE ASSOCIATED COST. ADDITIONALLY, WE COMPLETED VALIDATION OF A MULTIPLEXED ARRAY THAT MEASURES MULTIPLE MALARIA ANTIGENS AT LOW CONCENTRATIONS TO SUPPORT THE DEVELOPMENT OF IMPROVED RAPID DIAGNOSTIC TESTS.WITH PARTNERS, PATH ESTABLISHED A BIOREPOSITORY TO SUPPORT THE DEVELOPMENT OF IMPROVED PREECLAMPSIA DIAGNOSTICS. ADDITIONALLY, PATH CREATED NEW TRAINING MATERIALS, INCLUDING A USER AID, TO SUPPORT OPERATIONS RESEARCH ON AN IMPROVED PREECLAMPSIA TEST.IN COLLABORATION WITH A PRIVATE-SECTOR PARTNER, PATH WORKED TO SIGNIFICANTLY LOWER THE PRICE PER ANALYTE FOR A MULTIPLEXED TOOL THAT DETECTS UP TO SEVEN NUTRITION- AND DISEASE-RELATED BIOMARKERS FOR POPULATION-BASED SURVEILLANCE OF MICRONUTRIENT DEFICIENCIES.FURTHER, PATH AND OUR PARTNERS CONDUCTED FIELD STUDIES AND MARKET RESEARCH TO ASSESS AND VALIDATE THE APPLICATION OF A BOVINE ESTRUS DETECTION TEST IN LOW- AND MIDDLE-INCOME COUNTRIES TO IMPROVE LIVELIHOODS AND NUTRITION. THE PRODUCT WAS LAUNCHED WITH DISTRIBUTION PARTNERS IN KENYA, TANZANIA, AND UGANDA.IMPACT LABSPATH'S IMPACT LABS IN INDIA, KENYA, AND SOUTH AFRICA HELP TO ADVANCE THE MOST PROMISING HEALTH TECHNOLOGIES. THESE COUNTRIES HAVE RICH INNOVATION ECOSYSTEMS WITH UNIVERSITIES, PRIVATE-SECTOR FIRMS, AND A GROWING NUMBER OF ENTREPRENEURS FOCUSED ON INNOVATIVE PRODUCTS AND SERVICES THAT MAKE HEALTH CARE MORE AFFORDABLE, ACCESSIBLE, AND EFFECTIVE. THROUGH OUR NETWORK OF IMPACT LABS, PATH CAN LEVERAGE WORLD-CLASS GLOBAL AND COUNTRY EXPERTISE TO ACCELERATE THE DEVELOPMENT AND INTRODUCTION OF SCALABLE DEVICES, TOOLS, AND DIAGNOSTICS FOR HEALTH. THE KENYA IMPACT LAB WAS IN NASCENT STAGES IN 2018; ACTIVITIES FOR INDIA AND SOUTH AFRICA ARE DESCRIBED BELOW. THE INDIA IMPACT LAB WAS OFFICIALLY LAUNCHED IN JANUARY 2018 IN PARTNERSHIP WITH TATA TRUSTS AND THE INDIAN INSTITUTE OF TECHNOLOGY DELHI AS A PLATFORM TO ENABLE LATE-STAGE MEDICAL TECHNOLOGY (MEDTECH) INNOVATIONS TO ACHIEVE MARKET ENTRY, ADOPTION, AND SCALE-UP. IN JULY 2018, THE IMPACT LAB LAUNCHED A 12-MONTH INTENSIVE PROGRAM: SOCIAL ALPHA QUEST FOR HEALTHCARE INNOVATIONS. THE QUEST FEATURED A SYSTEMATIC, COHORT-BASED ENGAGEMENT MODEL WITH TEN SELECTED MEDTECH PRODUCT START-UPS. THE PROGRAM PROVIDED THE START-UPS WITH CONTEXTUAL SUPPORT, GUIDANCE, AND MENTORSHIP IN PRODUCT DEVELOPMENT, CLINICAL EVIDENCE GENERATION, REGULATIONS, QUALITY MANAGEMENT, MARKET UNDERSTANDING, AND PROCUREMENT CHANNELS. THE IMPACT LAB PARTNERED AND SIGNED MEMORANDUMS OF UNDERSTANDING WITH FIVE TOP INDIAN TECHNOLOGY AND BUSINESS INCUBATORS IN THE LIFE SCIENCE AND HEALTH CARE INDUSTRIES TO CONDUCT JOINT PROGRAMS FOR THE DEVELOPMENT OF THE INNOVATION ECOSYSTEM. THE IMPACT LAB ALSO DELIVERED EIGHT CURATED AND FOCUSED KNOWLEDGE PLATFORMS (FOR EXAMPLE, WORKSHOPS, ROUNDTABLES, AND MENTOR MIXERS). FOR THESE, THE IMPACT LAB ENGAGED EXPERTS FROM NUMEROUS LARGE AND SMALL MEDTECH COMPANIES. IN 2018, 60 TO 100 START-UPS PARTICIPATED IN EACH KNOWLEDGE PLATFORM (PRODUCT DEVELOPMENT, LOCAL AND GLOBAL REGULATIONS, STANDARDS, TESTING AND CALIBRATIONS, CERTIFICATION, VENDOR MANAGEMENT, QUALITY MANAGEMENT, AND MARKET ENTRY ASPECTS)-ALL HIGHLY RELEVANT TO THE GROWTH OF MEDTECH START-UPS AND THE INNOVATION ECOSYSTEM.FOR THE SOUTH AFRICA IMPACT LAB, A PRIMARY FOCUS OF 2018 WAS TO RE-ENGAGE AND RE-AFFIRM PATH'S RELATIONSHIP WITH THE SOUTH AFRICAN MEDICAL RESEARCH COUNCIL (SAMRC) AND COMMITMENT TO OUR JOINT GLOBAL HEALTH INNOVATION ACCELERATOR (GHIA) PARTNERSHIP. FOR EXAMPLE, PATH FACILITATED A WORKSHOP WITH THE SAMRC REGARDING KEY COMMERCIALIZATION AND MARKET DYNAMICS CONCEPTS. WE ALSO PROVIDED TECHNICAL ASSISTANCE TO THE SAMRC AND OTHER PARTNERS ON A SUCCESSFUL GRAND CHALLENGES CANADA APPLICATION FOR A MATERNAL HEALTH MEDICAL DEVICE. THESE AND OTHER ACTIVITIES WERE CONDUCTED UNDER A GRANT FROM THE BILL & MELINDA GATES FOUNDATION TO THE SAMRC. THE GRANT WAS AIMED AT BUILDING GHIA'S CAPACITY TO IMPROVE THE AFFORDABILITY AND AVAILABILITY OF HEALTH CARE SERVICES BY SUPPORTING THE DEVELOPMENT AND COMMERCIALIZATION OF MEDICAL TECHNOLOGIES DESIGNED FOR RESOURCE-LIMITED SETTINGS IN SOUTH AFRICA AND BEYOND.MARKET DYNAMICSPATH'S MARKET DYNAMICS PROGRAM ENCOMPASSES EFFORTS TO CHARACTERIZE MARKETS, ASSESS SHORTCOMINGS, AND DESIGN MARKET-BASED INTERVENTIONS TO IMPROVE HEALTH OUTCOMES. THIS WORK COMPLEMENTS PATH'S OTHER EFFORTS, SUCH AS PRODUCT DEVELOPMENT AND INTRODUCTION. IT BUILDS UPON OUR EXISTING STRENGTH IN COMMERCIALIZATION, ALIGNS EXPERTISE ACROSS TEAMS, AND EXPANDS OUR CAPACITY TO ADDRESS MARKET-BASED ISSUES. IN 2018, OUR WORK FOCUSED ON ASSESSING MARKETS AND IMPROVING MARKET FUNCTIONING FOR MALARIA DRUGS AND DRUG INTERMEDIATES, MALARIA DIAGNOSTICS, OXYGEN THERAPY DEVICES, AND DEVICES FOR TREATMENT OF PRECANCEROUS CERVICAL LESIONS. THE MARKET DYNAMICS PROGRAM ALSO COLLABORATED WITH THE ADVOCACY AND PUBLIC POLICY TEAM TO STRENGTHEN MARKETS FOR MATERNAL AND NEWBORN HEALTH PRODUCTS THROUGH POLICY ADVOCACY.
(Code:   ) (Expenses $ 25,764,391 including grants of $ 5,244,395 ) (Revenue $   )
ADVOCACY AND PUBLIC POLICY:PATH'S ADVOCACY AND PUBLIC POLICY TEAM WORKS IN THE UNITED STATES, GLOBALLY WITH MULTILATERAL AGENCIES ENGAGED IN HEALTH POLICY AND PLANNING, AND IN COUNTRIES AND COMMUNITIES AROUND THE WORLD. WE HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH EFFORTS. IN 2018, PATH LED ADVOCACY EFFORTS TO ENSURE SUPPORT AMONG POLICYMAKERS IN THE UNITED STATES AND EUROPE FOR RESEARCH AND DEVELOPMENT, MATERNAL AND CHILD HEALTH, IMMUNIZATION, AND GLOBAL HEALTH SECURITY. ONE EXAMPLE OF OUR SUCCESS WAS PASSAGE OF TWO POLICIES IN THE UNITED STATES THAT SOLIDIFIED US GOVERNMENT SUPPORT FOR RESEARCH AND DEVELOPMENT IN ITS GLOBAL HEALTH PROGRAMS. THANKS IN PART TO PATH'S EFFORTS TO EDUCATE MEMBERS OF CONGRESS, US GOVERNMENT FUNDING WAS MAINTAINED OR INCREASED FOR MATERNAL AND CHILD HEALTH, IMMUNIZATION, AND GLOBAL HEALTH RESEARCH AND DEVELOPMENT PROGRAMS.WORKING WITH PARTNERS IN AFRICAN COUNTRIES, WE HELPED ADVANCE POLICIES TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN. AMONG MANY ACHIEVEMENTS DURING 2018, IN KENYA, YEARS OF ADVOCACY BY PATH RESULTED IN PASSAGE OF THE FIRST COMPREHENSIVE POLICY THAT HARMONIZES DELIVERY OF HEALTH CARE FOR CHILDREN FROM BIRTH THROUGH ADOLESCENCE. IN THE DRC, A NATIONAL STRATEGY AND A SUBNATIONAL POLICY WERE ADOPTED TO PRIORITIZE ELIMINATION OF HUMAN AFRICAN TRYPANOSOMIASIS, ALSO KNOWN AS SLEEPING SICKNESS. IN SOUTH AFRICA, PATH'S ADVOCACY INFLUENCED THE PRIORITIZATION OF RESEARCH AND DEVELOPMENT FOR HEALTH IN A NATIONAL POLICY FOR SCIENCE, TECHNOLOGY, AND INNOVATION. AND IN UGANDA, PATH SUCCESSFULLY ADVOCATED FOR FUNDS TO BE ALLOCATED FOR VACCINE DISTRIBUTION.SPECIAL INITIATIVES:PATH IS ENGAGED IN A VARIETY OF SPECIAL INITIATIVES THAT GALVANIZE OUR EXPERTISE AND RESOURCES AND THOSE OF OUR GLOBAL PARTNERS TO SAVE MORE LIVES, MORE QUICKLY. BY THE END OF 2018, WE HAD ACTIVE HEALTH IMPACT TEAMS IN SEVEN HEALTH AREAS: MALARIA; HIV/AIDS; MATERNAL, NEWBORN, AND CHILD HEALTH; NUTRITION; SEXUAL AND REPRODUCTIVE HEALTH; EPIDEMIC PREPAREDNESS AND RESPONSE/GLOBAL HEALTH SECURITY INNOVATION; AND HEALTH SYSTEMS STRENGTHENING/PRIMARY HEALTH CARE. EACH HEALTH IMPACT TEAM GOES THROUGH A STAGED PROCESS OF SCALE-UP AND GROWTH. THESE TEAMS DEVELOP AND EVOLVE STRATEGY, STRENGTHEN AND CONNECT PATH TALENT ACROSS GEOGRAPHIES AND PROGRAMS, AND FOCUS ON REVENUE GENERATION FOR PATH THROUGH EXTERNAL ENGAGEMENT AND POSITIONING WITH KEY PARTNERS AND DONORS.
4d Other program services (Describe in Schedule O.)
(Expenses $ 25,764,391 including grants of $ 5,244,395 ) (Revenue $   )
4e Total program service expensesMediumBullet268,781,059
Form 990 (2018)
Form 990 (2018)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part IClick to see attachment.............
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part IIClick to see attachment..............
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C, Part IIIClick to see attachment.................
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part IClick to see attachment..................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part IIClick to see attachment...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes," complete Schedule D, Part IIIClick to see attachment.............
8
 
No
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IVClick to see attachment..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi-endowments? If "Yes," complete Schedule D, Part VClick to see attachment......
10
Yes
 
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10?
If "Yes," complete Schedule D, Part VI.Click to see attachment...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment.......
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIIClick to see attachment.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IXClick to see attachment............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part XClick to see attachment
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment
11f
 
No
12a
Did the organization obtain separate, independent audited financial statements for the tax year?
If "Yes," complete Schedule D, Parts XI and XII Click to see attachment.................
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States? .....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV.........Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV.....Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I(see instructions) ....
17
 
No
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............
18
 
No
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.....Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........Click to see attachment
22
Yes
 
Form 990 (2018)
Form 990 (2018)
Page 4
Part IV
Checklist of Required Schedules (continued)
Yes
No
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I............
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I...................
25b
 
No
26
Did the organization report any amount on Part X, line 5, 6, or 22 for receivables from or payables to any current or former officers, directors, trustees, key employees, highest compensated employees, or disqualified persons? If "Yes," complete Schedule L, Part II................
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor or employee thereof, a grant selection committee member, or to a 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part III.........
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If "Yes," complete Schedule L,
Part IV........................
28a
 
No
b
A family member of a current or former officer, director, trustee, or key employee? If "Yes," complete Schedule L, Part IV.....................
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or direct or indirect owner? If "Yes," complete Schedule L, Part IV...
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..Click to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M .............Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I.
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II...........
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I........Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1.........................Click to see attachment
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
Yes
 
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ...Click to see attachment
35b
Yes
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2............. Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........
Yes
No
1a
Enter the number reported in Box 3 of Form 1096 Enter -0- if not applicable ..
1a
230
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
Form 990 (2018)
Form 990 (2018)
Page 5
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
787
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
Yes
 
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
Yes
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletBE , CH , CG , ET , GH , IN , KE , BM , MZ , PE , SG , SF , SZ , TZ , UG , UK , UP , VM , ZA
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................
7a
 
No
b
If "Yes," did the organization notify the donor of the value of the goods or services provided? .....
7b
 
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds.
Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? .........................
8
 
 
9a
Did the sponsoring organization make any taxable distributions under section 4966?...
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
15
Is the organization subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or excess parachute payment(s) during the year? If "Yes," see instructions and file Form 4720, Schedule N .....
15
 
No
16
Is the organization an educational institution subject to the section 4968 excise tax on net investment income?
If "Yes," complete Form 4720, Schedule O ................
16
 
No
Form 990 (2018)
Form 990 (2018)
Page 6
Part VI
Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
1a
14
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent
1b
14
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? .
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
 
No
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .......................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
 
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done...................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
AL , AR , CA , CT , FL , IL , KS , KY , MA , MD , MI , MN , MS , NC , NH , NJ , NM , NY , OK , OR , PA , RI , SC , TN , UT , VA , WI , WV
18
Section 6104 requires an organization to make its Form 1023 (or 1024-A if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBulletBRIAN NEVILLE CHIEF OF ACCOUNTING2201 WESTLAKE AVE SUITE 200   SEATTLE,WA98121 (206) 285-3500
Form 990 (2018)
Form 990 (2018)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) DAVID KING......................................................................
CHAIR
 2.00
.................
0.00 		X   X       0 0 0
(2) FELIX OLALE......................................................................
VICE CHAIR
 2.00
.................
0.00 		X   X       0 0 0
(3) YEHONG ZHANG......................................................................
SECRETARY
 2.00
.................
0.00 		X   X       0 0 0
(4) BRUCE MCNAMER......................................................................
TREASURER
 2.00
.................
0.00 		X   X       0 0 0
(5) DEAN ALLEN......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(6) PEGGY JOHNSON......................................................................
DIRECTOR (UNTIL 12/2018)
 2.00
.................
0.00 		X           0 0 0
(7) GARY LOCKE......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(8) JO ADDY......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(9) IREENA VITTAL......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(10) DEANNA OPPENHEIMER......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(11) JOEL HOLSINGER......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(12) JOHN-ARNE ROTTINGEN......................................................................
DIRECTOR
 2.00
.................
0.00 		X           0 0 0
(13) HELENA WAYTH......................................................................
DIRECTOR (BEGAN 6/2018)
 2.00
.................
0.00 		X           0 0 0
(14) TSITSI MASIYIWA......................................................................
DIRECTOR (UNTIL 3/2018)
 2.00
.................
0.00 		X           0 0 0
(15) DENNIS SCHMATZ......................................................................
DIRECTOR (UNTIL 3/2018)
 2.00
.................
0.00 		X           0 0 0
(16) BETH GALETTI......................................................................
DIRECTOR (BEGAN 12/2018)
 2.00
.................
0.00 		X           0 0 0
(17) SANFORD MELZER......................................................................
DIRECTOR (BEGAN 12/2018)
 2.00
.................
0.00 		X           0 0 0
Form 990 (2018)
Form 990 (2018)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(18) STEPHEN B DAVIS........................................................................
PRESIDENT AND CEO
 38.00
.......................2.00 		    X       665,877 0 62,780
(19) OLIVIA D POLIUS........................................................................
CHIEF FINANCIAL OFFICER
 38.00
.......................2.00 		    X       320,646 0 51,936
(20) DANIEL LASTER........................................................................
COO AND GENERAL COUNSEL
 38.00
.......................2.00 		    X       310,669 0 41,544
(21) DAVID C KASLOW........................................................................
VP - PRODUCT DEVELOPMENT
 38.00
.......................2.00 		      X     379,045 0 65,678
(22) AMIE E BATSON........................................................................
CHIEF STRATEGY OFFICER
 39.00
.......................1.00 		      X     378,150 0 22,577
(23) KATHY CAHILL........................................................................
VP - INTERNATIONAL DEVELOPMENT
 40.00
.......................0.00 		      X     345,013 0 26,620
(24) DAVID W FLEMING........................................................................
VP - PUBLIC HEALTH IMPACT
 40.00
.......................0.00 		      X     286,869 0 50,611
(25) KATHRYN A O'DRISCOLL........................................................................
CHIEF HUMAN RESOURCES OFFICER
 40.00
.......................0.00 		      X     279,820 0 27,714
(26) ERICA J SESSLE........................................................................
CHIEF OF STAFF
 40.00
.......................0.00 		      X     214,378 0 34,734
(27) PRAVEEN RAJA........................................................................
VP - TECH. DEV. & INNOVATION
 40.00
.......................0.00 		      X     333,003 0 31,412
(28) ELAINE L GIBBONS........................................................................
VP - GLOBAL ENGAGEMENT
 40.00
.......................0.00 		      X     265,826 0 65,813
(29) JEFFREY D BERSON........................................................................
ASSOCIATE DIRECTOR II
 40.00
.......................0.00 		        X   431,451 0 82,104
(30) JAMES B MCKENNA........................................................................
ASSOCIATE DIRECTOR II
 40.00
.......................0.00 		        X   396,308 0 75,232
(31) TRAD M HATTON........................................................................
CHIEF OF PARTY
 40.00
.......................0.00 		        X   321,206 0 48,784
(32) BRUCE LAMONT INNIS........................................................................
GLOBAL DISEASE AREA HEAD
 40.00
.......................0.00 		        X   311,376 0 26,645
(33) JOHN O KONZ........................................................................
GLOBAL INT. PORT/FIN MGMT. CVIA HEAD
 40.00
.......................0.00 		        X   299,215 0 64,603
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)...........MediumBullet 5,538,852 0 778,787
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization MediumBullet340
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
WIDENET CONSULTING GROUP LLC

2910 1ST AVE S 200
SEATTLE,WA98134 		CONSULTING 821,832
RANDSTAD INDIA PVT LTD

BLDG 9 STES 001/002 JASOLA
NEW DELHI   110025
IN 		STAFFING SERVICES 715,744
WMBE PAYROLLING DBA TARGET CW

9475 CHESAPEAKE DRIVE
SAN DIEGO,CA92123 		GENERAL CONTRACTOR 564,411
SLALOM LLC

821 2ND AVE SUITE 1900
SEATTLE,WA98104 		CONSULTING 488,798
UNIFY CONSULTING LLC

1518 1ST AVE S STE 201
SEATTLE,WA98134 		CONSULTING 471,870
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet51
Form 990 (2018)
Form 990 (2018)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII.............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512 - 514
Contributions, Gifts, GrantAmt and OtherAmt Similar Amounts 1a Federated campaigns..1a  
b Membership dues..1b  
c Fundraising events..1c  
d Related organizations1d 23,547,825
e Government grants (contributions)1e 112,897,926
f All other contributions, gifts, grants, and similar amounts not included above1f 168,869,470
g Noncash contributions included in lines 1a - 1f:$ 259,914
h Total. Add lines 1a-1f.......MediumBullet 305,315,221
Program Service RevenueAmt Business Code
2a CONSULTANCIES 541900 1,500 1,500    
b
c
d
e
f All other program service revenue.        
g Total. Add lines 2a–2f ....MediumBullet 1,500
OtherAmtRevenueAmt 3 Investment income (including dividends, interest, and othersimilar amounts) ......MediumBullet 2,963,587     2,963,587
4 Income from investment of tax-exempt bond proceedsMediumBullet        
5 Royalties...........MediumBullet        
(ii) Personal (i) Real
6a Gross rents    
b Less: rental expenses    
c Rental income or (loss)    
d Net rental income or (loss)......MediumBullet        
(ii) Other (i) Securities
7a Gross amount from sales of assets other than inventory 547,000 78,640,623
b Less: cost or other basis and sales expenses 548,448 78,565,632
c Gain or (loss) -1,448 74,991
d Net gain or (loss).....MediumBullet 73,543     73,543
8a Gross income from fundraising events (not including $   of contributions reported on line 1c). See Part IV, line 18 ....
a  
b Less: direct expenses ...b  
c Net income or (loss) from fundraising events..MediumBullet      
9a Gross income from gaming activities.
See Part IV, line 19 ...
a  
b Less: direct expenses ...b  
c Net income or (loss) from gaming activities..MediumBullet        
10a Gross sales of inventory, less
returns and allowances ..
a  
b Less: cost of goods sold ..b  
c Net income or (loss) from sales of inventory..MediumBullet        
Business Code Miscellaneous Revenue
11a OTHER 900099 884,888     884,888
b REIMBURSEMENTS 900099 95,672     95,672
c            
d All other revenue ....        
e Total. Add lines 11a–11d ...... MediumBullet 980,560
12 Total revenue. See Instructions......MediumBullet 309,334,411 1,500 0 4,017,690
Form 990 (2018)
Form 990 (2018)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX..............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 20,575,733 20,575,733
2 Grants and other assistance to domestic individuals. See Part IV, line 22 9,313 9,313
3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, line 15 and 16. 42,177,100 42,177,100
4 Benefits paid to or for members    
5 Compensation of current officers, directors, trustees, and key employees .... 4,260,713 309,550 3,899,884 51,279
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....        
7 Other salaries and wages 102,073,963 74,628,680 26,015,749 1,429,534
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 10,426,617   10,426,617  
9 Other employee benefits ....... 16,197,399 1,718,558 14,478,841  
10 Payroll taxes ........... 6,586,983 3,707 6,583,276  
11 Fees for services (non-employees):        
a Management ......        
b Legal ......... 394,432 171,093 223,097 242
c Accounting ........... 331,915 33,164 298,751  
d Lobbying ........... 26,000 12,000 14,000  
e Professional fundraising services. See Part IV, line 17    
f Investment management fees ...... 207,672   207,672  
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) 20,027,156 13,543,689 6,447,874 35,593
12 Advertising and promotion .... 165,753 90,386 7,269 68,098
13 Office expenses ....... 8,810,563 7,390,713 1,376,052 43,798
14 Information technology ...... 732,838 219,457 465,295 48,086
15 Royalties .. 381,001 202,061 178,910 30
16 Occupancy ........... 12,048,542 389,297 11,659,245  
17 Travel ............ 19,986,534 18,565,722 1,358,161 62,651
18 Payments of travel or entertainment expenses for any federal, state, or local public officials .        
19 Conferences, conventions, and meetings .... 8,333,110 8,022,756 269,979 40,375
20 Interest ........... 8,819   8,819  
21 Payments to affiliates .......        
22 Depreciation, depletion, and amortization .. 2,974,173 3,101 2,971,072  
23 Insurance ... 725,361 187,114 538,247  
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a SUBCONTRACTS 24,705,297 23,525,529 1,132,123 47,645
b EQUIP RENT & MAINT 3,443,347 2,203,342 1,236,793 3,212
c LEAVE & BENS ALLOC 0 36,911,256 -37,679,297 768,041
d FACILITIES ALLOC 0 12,623,474 -12,990,044 366,570
e All other expenses 7,156,135 5,264,264 1,670,390 221,481
25 Total functional expenses. Add lines 1 through 24e 312,766,469 268,781,059 40,798,775 3,186,635
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720).        
Form 990 (2018)
Form 990 (2018)
Page 11
Part X
Balance Sheet
Check if Schedule O contains a response or note to any line in this Part IX..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ........ 3,035,980 1 7,576,050
2 Savings and temporary cash investments ......... 3,493,254 2 14,017,223
3 Pledges and grants receivable, net ...... 254,454,281 3 35,571,476
4 Accounts receivable, net ............. 13,578,928 4 10,652,789
5 Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L .............
  5  
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L ..............
  6  
7 Notes and loans receivable, net ....   7  
8 Inventories for sale or use ........   8  
9 Prepaid expenses and deferred charges ...... 4,753,758 9 5,307,245
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 36,534,903
b Less: accumulated depreciation 10b 25,486,998 11,878,205 10c 11,047,905
11 Investments—publicly traded securities . 176,133,425 11 153,328,545
12 Investments—other securities. See Part IV, line 11 .....   12  
13 Investments—program-related. See Part IV, line 11 ..   13  
14 Intangible assets ...............   14  
15 Other assets. See Part IV, line 11 ........... 619,867 15 0
16 Total assets. Add lines 1 through 15 (must equal line 34)... 467,947,698 16 237,501,233
Liabilities 17 Accounts payable and accrued expenses ..... 50,220,817 17 202,736,996
18 Grants payable ...   18  
19 Deferred revenue .........   19  
20 Tax-exempt bond liabilities .........   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D   21  
22 Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L..   22  
23 Secured mortgages and notes payable to unrelated third parties .. 576,675 23 194,878
24 Unsecured notes and loans payable to unrelated third parties ..   24  
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D   25  
26 Total liabilities. Add lines 17 through 25.. 50,797,492 26 202,931,874
Net Assets or Fund Balance Organizations that follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets 25,292,293 27 19,811,400
28 Temporarily restricted net assets ........... 388,460,737 28 14,757,959
29 Permanently restricted net assets 3,397,176 29 0
Organizations that do not follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds .....   30  
31 Paid-in or capital surplus, or land, building or equipment fund ...   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ........... 417,150,206 33 34,569,359
34 Total liabilities and net assets/fund balances ........ 467,947,698 34 237,501,233
Form 990 (2018)
Form 990 (2018)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
309,334,411
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
312,766,469
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
-3,432,058
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) ..
4
417,150,206
5
Net unrealized gains (losses) on investments ...............
5
-393,146
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
-378,755,643
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 33, column (B))
10
34,569,359
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII.............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?
3a
Yes
 
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
Yes
 
Form 990 (2018)
Form 990 (2018)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ.
right arrow Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2018
Open to Public
Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)
1
2
3
4
5
6
7
8
9

10
11
12
a
b
c
d
e
f
Enter the number of supported organizations ...............................  
g
Provide the following information about the supported organization(s).
(i) Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 10 above (see instructions)) (iv) Is the organization listed in your governing document? (v) Amount of monetary support (see instructions) (vi) Amount of other support (see instructions)
Yes No
Total
 
   
For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2018

Schedule A (Form 990 or 990-EZ) 2018
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv), 170(b)(1)(A)(vi), and 170(b)(1)(A)(ix)
(Complete only if you checked the box on line 5, 7, 8, or 9 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2014 (b) 2015 (c) 2016 (d) 2017 (e) 2018 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. 286,891,535 243,499,792 298,315,988 347,844,394 305,316,107 1,481,867,816
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3 286,891,535 243,499,792 298,315,988 347,844,394 305,316,107 1,481,867,816
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. 647,466,981
6 Public support. Subtract line 5 from line 4. 834,400,835
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2014 (b) 2015 (c) 2016 (d) 2017 (e) 2018 (f) Total
7 Amounts from line 4.. 286,891,535 243,499,792 298,315,988 347,844,394 305,316,107 1,481,867,816
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... 1,370,599 1,471,233 1,797,794 2,050,888 2,963,587 9,654,101
9 Net income from unrelated business activities, whether or not the business is regularly carried on.. 38,502         38,502
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. 763,131 2,551,502 4,668,393 5,225,302 980,560 14,188,888
11 Total support. Add lines 7 through 10 1,505,749,307
12
12
250,697
13
First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................right arrow
Section C. Computation of Public Support Percentage
14
14
55.410 %
15
15
59.120 %
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990 or 990-EZ) 2018

Schedule A (Form 990 or 990-EZ) 2018
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2014 (b) 2015 (c) 2016 (d) 2017 (e) 2018 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose            
3 Gross receipts from activities that are not an unrelated trade or business under section 513 .....            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge            
6 Total. Add lines 1 through 5            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support. (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2014 (b) 2015 (c) 2016 (d) 2017 (e) 2018 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2018

Schedule A (Form 990 or 990-EZ) 2018
Page 4
Part IV
Supporting Organizations
(Complete only if you checked a box on line 12 of Part I. If you checked 12a of Part I, complete Sections A and B. If you checked 12b of Part I, complete Sections A and C. If you checked 12c of Part I, complete Sections A, D, and E. If you checked 12d of Part I, complete Sections A and D, and complete Part V.)
Section A. All Supporting Organizations
Yes
No
1
Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.
1
 
 
2
Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).
2
 
 
3a
Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.
3a
 
 
b
Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.
3b
 
 
c
Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.
3c
 
 
4a
Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 12a or 12b in Part I, answer (b) and (c) below.
4a
 
 
b
Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.
4b
 
 
c
Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.
4c
 
 
5a
Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).
5a
 
 
b
Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?
5b
 
 
c
Substitutions only. Was the substitution the result of an event beyond the organization's control?
5c
 
 
6
Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.
6
 
 
7
Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .
7
 
 
8
Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).
8
 
 
9a
Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.
9a
 
 
b
Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.
9b
 
 
c
Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.
9c
 
 
10a
Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.
10a
 
 
b
Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).
10b
 
 
Schedule A (Form 990 or 990-EZ) 2018

Schedule A (Form 990 or 990-EZ) 2018
Page 5
Part IV
Supporting Organizations (continued)
Yes
No
11
Has the organization accepted a gift or contribution from any of the following persons?
a
A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?
11a
 
 
b
A family member of a person described in (a) above?
11b
 
 
c
A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.
11c
 
 
Section B. Type I Supporting Organizations
Yes
No
1
Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.
1
 
 
2
Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.
2
 
 
Section C. Type II Supporting Organizations
Yes
No
1
Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).
1
 
 
Section D. All Type III Supporting Organizations
Yes
No
1
Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?
1
 
 
2
Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).
2
 
 
3
By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.
3
 
 
Section E. Type III Functionally-Integrated Supporting Organizations
1
Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):
a
b
c
2
Activities Test. Answer (a) and (b) below.
Yes
No
a
Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.
2a
 
 
b
Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.
2b
 
 
3
Parent of Supported Organizations. Answer (a) and (b) below.
a
Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.
3a
 
 
b
Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.
3b
 
 
Schedule A (Form 990 or 990-EZ) 2018

Schedule A (Form 990 or 990-EZ) 2018
Page 6
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations
1
Section A - Adjusted Net Income (A) Prior Year (B) Current Year
(optional)
1 Net short-term capital gain 1    
2 Recoveries of prior-year distributions 2    
3 Other gross income (see instructions) 3    
4 Add lines 1 through 3 4    
5 Depreciation and depletion 5    
6 Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) 6    
7 Other expenses (see instructions) 7    
8 Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) 8    
Section B - Minimum Asset Amount (A) Prior Year (B) Current Year
(optional)
1 Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): 1
a Average monthly value of securities 1a    
b Average monthly cash balances 1b    
c Fair market value of other non-exempt-use assets 1c    
d Total (add lines 1a, 1b, and 1c) 1d    
e Discount claimed for blockage or other factors
(explain in detail in Part VI):  
2 Acquisition indebtedness applicable to non-exempt use assets 2    
3 Subtract line 2 from line 1d 3    
4 Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). 4    
5 Net value of non-exempt-use assets (subtract line 4 from line 3) 5    
6 Multiply line 5 by .035 6    
7 Recoveries of prior-year distributions 7    
8 Minimum Asset Amount (add line 7 to line 6) 8    
Section C - Distributable Amount Current Year
1 Adjusted net income for prior year (from Section A, line 8, Column A) 1  
2 Enter 85% of line 1 2  
3 Minimum asset amount for prior year (from Section B, line 8, Column A) 3  
4 Enter greater of line 2 or line 3 4  
5 Income tax imposed in prior year 5  
6 Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) 6  
7
Schedule A (Form 990 or 990-EZ) 2018

Schedule A (Form 990 or 990-EZ) 2018
Page 7
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations (continued)
Section D - Distributions Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes  
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in
excess of income from activity		  
3 Administrative expenses paid to accomplish exempt purposes of supported organizations  
4 Amounts paid to acquire exempt-use assets  
5 Qualified set-aside amounts (prior IRS approval required)  
6 Other distributions (describe in Part VI). See instructions  
7Total annual distributions. Add lines 1 through 6.  
8 Distributions to attentive supported organizations to which the organization is responsive (provide
details in Part VI). See instructions		  
9 Distributable amount for 2018 from Section C, line 6  
10 Line 8 amount divided by Line 9 amount  
Section E - Distribution Allocations (see instructions) (i)
Excess Distributions 		(ii)
Underdistributions
Pre-2018 		(iii)
Distributable
Amount for 2018
1 Distributable amount for 2018 from Section C, line
6 		 
2 Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI).
See instructions.		  
3 Excess distributions carryover, if any, to 2018:
a From 2013.......  
b From 2014.......  
c From 2015.......  
d From 2016.......  
e From 2017.......  
fTotal of lines 3a through e  
g Applied to underdistributions of prior years  
h Applied to 2018 distributable amount  
i Carryover from 2013 not applied (see
instructions) 		 
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.  
4Distributions for 2018 from Section D, line 7:
$  
a Applied to underdistributions of prior years  
b Applied to 2018 distributable amount  
c Remainder. Subtract lines 4a and 4b from 4.  
5 Remaining underdistributions for years prior to
2018, if any. Subtract lines 3g and 4a from line 2.
If the amount is greater than zero, explain in Part VI.
See instructions.		  
6 Remaining underdistributions for 2018. Subtract
lines 3h and 4b from line 1. If the amount is greater
than zero, explain in Part VI. See instructions.		  
7 Excess distributions carryover to 2019. Add lines
3j and 4c.		  
8 Breakdown of line 7:
a Excess from 2014......  
b Excess from 2015.....  
c Excess from 2016.....  
d Excess from 2017.....  
e Excess from 2018.....  
Schedule A (Form 990 or 990-EZ) (2018)

Schedule A (Form 990 or 990-EZ) 2018
Page 8
Part VI
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Return Reference Explanation
Schedule A (Form 990 or 990-EZ) 2018


Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors

Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2018
Name of the organization
PATH
 
Employer identification number

91-1157127
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ






Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......... Arrow Bullet $  
Caution. An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2018)
Schedule B (Form 990, 990-EZ, or 990-PF) (2018) Page 2
Name of organization
PATH
  		Employer identification number
91-1157127
Part I
Contributors (See instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
 
 
 
 
  ,    

$ RESTRICTED


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)
Page 3
Name of organization
PATH
  		Employer identification number

91-1157127
Part II
Noncash Property (See instructions). Use duplicate copies of Part II if additional space is needed.
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)
Page 4
Name of organization
PATH
  		Employer identification number

91-1157127
Part III
Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Additional Data


Software ID:  
Software Version:  
SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet Complete if the organization is described below. SchCMd Bullet Attach to Form 990 or Form 990-EZ.
SchCMd BulletGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2018
Open to Public
Inspection
If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization’s direct and indirect political campaign activities in Part IV (see instructions for definition of “political campaign activities")

2
Political campaign activity expenditures (see instructions) ....................................................................SchCMd Bullet
$  
3
Volunteer hours for political campaign activities (see instructions) ..................................................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 ................................SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 .......................SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................
4a
Was a correction made? ......................................................................................................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c), except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b...........SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ...................................................................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6
For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.
Cat. No. 50084S
Schedule C (Form 990 or 990-EZ) 2018

Schedule C (Form 990 or 990-EZ) 2018
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check SchCMd Bulletexpenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
organization's
totals 		(b) Affiliated group totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ...................... 7,856  
b Total lobbying expenditures to influence a legislative body (direct lobbying) ............................... 217,088  
c Total lobbying expenditures (add lines 1a and 1b) ................................................................... 224,944  
d Other exempt purpose expenditures ........................................................................ 311,815,894  
e Total exempt purpose expenditures (add lines 1c and 1d) ............................................... 312,040,838  
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		 1,000,000  
If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
Not over $500,00020% of the amount on line 1e.
Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
Over $17,000,000$1,000,000.
g Grassroots nontaxable amount (enter 25% of line 1f) ................................................. 250,000  
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................ 0  
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................ 0  
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ...................................................................................................................

4-Year Averaging Period Under section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
Calendar year (or fiscal year
beginning in) 		(a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) Total
2a Lobbying nontaxable amount 1,000,000 1,000,000 1,000,000 1,000,000 4,000,000
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		6,000,000
c Total lobbying expenditures 156,961 168,991 294,096 224,944 844,992
d Grassroots nontaxable amount 250,000 250,000 250,000 250,000 1,000,000
e Grassroots ceiling amount
(150% of line 2d, column (e))		 1,500,000
f Grassroots lobbying expenditures 14,461 470 127,336 7,856 150,123
Schedule C (Form 990 or 990-EZ) 2018


Schedule C (Form 990 or 990-EZ) 2018
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.
(a)
No
Yes
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? ...........................................................................................................
 
 
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........
 
 
c
Media advertisements? ...................................................................................................
 
 
 
d
Mailings to members, legislators, or the public? .............................................................................
 
 
 
e
Publications, or published or broadcast statements? ...........................................................
 
 
 
f
Grants to other organizations for lobbying purposes? ..........................................................
 
 
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? .......................
 
 
 
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................
 
 
 
i
Other activities? ...................................................................................................................
 
 
 
j
Total. Add lines 1c through 1i ....................................................................................................
 
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
 
b
If "Yes," enter the amount of any tax incurred under section 4912 ...........................................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................
 
 
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ...............................................
1
 
 
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................
2
 
 
3
Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................
3
 
 
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."
1
Dues, assessments and similar amounts from members ......................................................................
1
 
2
Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).
a
Current year .............................................................................................................................
2a
 
b
Carryover from last year ............................................................................................................
2b
 
c
Total ...........................................................................................................................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................
4
 
5
Taxable amount of lobbying and political expenditures (see instructions) .........................................
5
 
Part IV
Supplemental Information
Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.
Return Reference Explanation
Schedule C (Form 990 or 990EZ) 2018


Additional Data


Software ID:  
Software Version:  

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet Attach to Form 990.
SchDMd Bullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2018
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements. Complete if the organization answered "Yes" on Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ...................... 2a  
b Total acreage restricted by conservation easements .................... 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............
6
Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included on Form 990, Part VIII, line 1 .........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:
a
Revenue included on Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2018

Schedule D (Form 990) 2018
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b If "Yes," explain the arrangement in Part XIII and complete the following table: Amount
c Beginning balance ............................. 1c  
d Additions during the year ............................ 1d  
e Distributions during the year .......................... 1e  
f Ending balance ................................ 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....
Part V
Endowment Funds. Complete if the organization answered "Yes" on Form 990, Part IV, line 10.
(a)Current year (b)Prior year (c)Two years back (d)Three years back (e)Four years back
1a Beginning of year balance .... 10,056,545 9,339,249 8,897,224 9,404,188 9,016,994
b Contributions ... 1,240 3,410 4,256 2,665 9,350
c Net investment earnings, gains, and losses -494,491 1,159,282 907,978 -58,783 768,184
d Grants or scholarships ...          
e Other expenditures for facilities
and programs ... 		467,377 445,396 470,209 450,846 390,340
f Administrative expenses ....          
g End of year balance ...... 9,095,917 10,056,545 9,339,249 8,897,224 9,404,188
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet36.000 %
b
Permanent endowment SchDMd Bullet37.000 %
c
Temporarily restricted endowment SchDMd Bullet27.000 %
The percentages on lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations .................
3a(i)
 
No
(ii) related organizations .................
3a(ii)
 
No
b
If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis
(investment) 		(b) Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .....      
b Buildings ....        
c Leasehold improvements   20,479,518 13,086,483 7,393,035
d Equipment ....   10,835,427 8,231,189 2,604,238
e Other .....   5,219,958 4,169,326 1,050,632
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..SchDMdBullet 11,047,905
Schedule D (Form 990) 2018

Schedule D (Form 990) 2018
Page 3
Part VII
Investments—Other Securities. Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1) Financial derivatives.........    
(2) Closely-held equity interests........    
(3)Other
(A)
(B)
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet  
Part VIII
Investments—Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
(1) Federal income taxes  
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet  
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2018

Schedule D (Form 990) 2018
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1  
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a  
b Donated services and use of facilities ......... 2b  
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d ..................... 2e  
3 Subtract line 2e from line 1.................. 3  
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b.................... 4c  
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5  
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1  
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities ......... 2a  
b Prior year adjustments ............ 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d.................... 2e  
3 Subtract line 2e from line 1................... 3  
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b..................... 4c  
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5  
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
PART V, LINE 4: IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY, PATH UTILIZES THE INCOME EARNED ON THE ENDOWMENT FUNDS AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH.
Schedule D (Form 990) 2018


Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2018
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in region (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total expenditures
for and investments
in region
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 14,826
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 979
CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTMAKING   380,632
EAST ASIA AND THE PACIFIC 4 89 MANAGEMENT & GENERAL   1,040,096
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 4,441,155
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 310,893
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 79,330
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES OTHER 2,940
EAST ASIA AND THE PACIFIC 0 0 FUNDRAISING   68,916
EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING   4,746,774
EUROPE 1 6 MANAGEMENT & GENERAL   20,005
EUROPE 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 1,565,902
EUROPE 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 4,020,990
EUROPE 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 205,993
EUROPE 0 0 PROGRAM SERVICES OTHER 3,105
EUROPE 0 0 FUNDRAISING   11,452
EUROPE 0 0 GRANTMAKING   23,522,629
MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 218
NORTH AMERICA 0 0 MANAGEMENT & GENERAL   56,482
NORTH AMERICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 121,949
NORTH AMERICA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 194,221
NORTH AMERICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 44,284
NORTH AMERICA 0 0 GRANTMAKING   733,350
RUSSIA AND NEIGHBORING STATES 1 24 MANAGEMENT & GENERAL   295,153
RUSSIA AND NEIGHBORING STATES 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 2,753,844
RUSSIA AND NEIGHBORING STATES 0 0 GRANTMAKING   1,133,768
SOUTH AMERICA 1 3 MANAGEMENT & GENERAL   48,946
SOUTH AMERICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 402,511
SOUTH AMERICA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 2,836
SOUTH AMERICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 3,228
SOUTH AMERICA 0 0 PROGRAM SERVICES OTHER 34
SOUTH AMERICA 0 0 GRANTMAKING   138,891
SOUTH ASIA 4 91 MANAGEMENT & GENERAL   1,420,932
SOUTH ASIA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 3,526,336
SOUTH ASIA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 493,818
SOUTH ASIA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 617,215
SOUTH ASIA 0 0 PROGRAM SERVICES OTHER 11,038
SOUTH ASIA 0 0 GRANTMAKING   1,886,168
SUB-SAHARAN AFRICA 36 817 MANAGEMENT & GENERAL   10,173,517
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 54,325,843
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 1,037,175
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 1,003,695
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES OTHER 1,581,091
SUB-SAHARAN AFRICA 0 0 FUNDRAISING   12,972
SUB-SAHARAN AFRICA 0 0 GRANTMAKING   9,634,888
3a Sub-total ..... 4 89 6,270,851
b Total from continuation sheets to Part I ...     125,820,169
c Totals (add lines 3a and 3b) 47 1,030 132,091,020
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2018
Schedule F (Form 990) 2018
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
CENTRAL AMERICA & THE CARIBBEAN GLOBAL HEALTH PROGRAMS 150,305 CHECK/WIRE      
CENTRAL AMERICA & THE CARIBBEAN GLOBAL HEALTH PROGRAMS 230,327 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 5,056 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 5,855 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 6,014 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 6,316 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 6,683 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 7,428 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 7,496 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 8,651 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 8,726 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 8,831 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 17,290 CHECK/WIRE      
EAST ASIA & THE PACIFIC TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 18,465 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 18,988 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 20,165 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 20,651 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 30,000 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 36,845 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS & ESSENTIAL MEDICINE 41,922 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 51,551 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 52,029 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 54,779 CHECK/WIRE      
EAST ASIA & THE PACIFIC TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 63,761 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 72,805 CHECK/WIRE      
EAST ASIA & THE PACIFIC TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 88,594 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 100,267 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 124,235 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 174,483 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 210,000 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 340,199 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 906,750 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 2,220,200 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 5,487 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 15,000 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 20,000 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 42,190 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 47,584 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 91,299 CHECK/WIRE      
EUROPE TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 95,018 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 100,000 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 110,493 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 125,000 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 184,850 CHECK/WIRE      
EUROPE TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 258,278 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 260,000 CHECK/WIRE      
EUROPE TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 330,632 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 331,139 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS & TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 350,000 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS & ESSENTIAL MEDICINE 672,105 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 858,186 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 1,127,499 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 1,636,289 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 13,537,059 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS, ESSENTIAL MEDICINE, TECHNOLOGY, ANALYTICS AND MARKET INNOVATION, AND OTHER 3,321,058 CHECK/WIRE      
NORTH AMERICA ESSENTIAL MEDICINE 38,669 CHECK/WIRE      
NORTH AMERICA ESSENTIAL MEDICINE 133,260 CHECK/WIRE      
NORTH AMERICA ESSENTIAL MEDICINE 561,421 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 15,822 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 17,708 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 17,925 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 21,417 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 23,824 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 28,182 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 30,506 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 33,192 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 36,049 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 39,440 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 40,919 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 44,199 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 55,632 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 72,476 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 89,186 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 114,306 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 115,520 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 148,673 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 188,791 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 20,000 CHECK/WIRE      
SOUTH AMERICA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 32,890 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 86,001 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 5,524 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE 10,449 CHECK/WIRE      
SOUTH ASIA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 15,000 CHECK/WIRE      
SOUTH ASIA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 23,210 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 40,450 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 54,148 CHECK/WIRE      
SOUTH ASIA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 70,000 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE & TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 76,827 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 85,762 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 189,652 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE 300,000 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE 461,944 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 553,203 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 6,044 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 6,663 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 6,731 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 7,853 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 10,474 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 10,577 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 10,653 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 10,742 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 11,068 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 11,364 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 12,207 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 12,240 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 12,567 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 12,698 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 12,773 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 13,336 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 13,567 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 13,740 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 13,937 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 14,232 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,345 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,403 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,423 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,444 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,548 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,596 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,786 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,828 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,913 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,941 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 15,024 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 15,232 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 15,475 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 15,706 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 17,894 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 19,200 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 20,424 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 20,918 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 21,623 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 21,769 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 22,301 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 23,061 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 23,327 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 24,586 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 24,953 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 25,222 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 27,010 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 27,314 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 27,323 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 28,097 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 28,185 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 28,842 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 29,409 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 29,615 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 30,553 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 33,176 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 37,570 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 37,612 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 38,771 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 39,283 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 42,015 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 42,522 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 42,821 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 45,000 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 45,005 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 49,896 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 50,367 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 51,041 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 51,721 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 53,203 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 53,323 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 61,616 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 70,705 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS & ESSENTIAL MEDICINE 86,825 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 90,313 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 92,565 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 94,051 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 94,299 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 109,395 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 116,943 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 136,668 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 143,568 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 154,101 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 199,361 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 289,929 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 328,475 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 372,808 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 386,133 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 1,520,852 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 3,632,614 CHECK/WIRE      
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
132
3 Enter total number of other organizations or entities .......................MediumBullet
50
Schedule F (Form 990) 2018
Schedule F (Form 990) 2018Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2018
Schedule F (Form 990) 2018
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2018
Schedule F (Form 990) 2018
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).
ReturnReference Explanation
PART I, LINE 2: PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2018
Additional Data


Software ID:  
Software Version:  




Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2018
Open to Public
Inspection
Name of the organization
PATH
 
Employer identification number
91-1157127
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient
that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
(if applicable)		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
noncash assistance		 (h) Purpose of grant
or assistance
(1) GLOBAL HEALTH CORPS
318 WEST 39TH STREET ROOM 9L
NEW YORK,NY10018 		80-0512336 501(C)(3) 6,456       GLOBAL HEALTH PROGRAMS
(2) MANAGEMENT SCIENCES FOR HEALTH
200 RIVERS EDGE DRIVE SUITE 320
MEDFORD,MA02155 		04-2482188 501(C)(3) 9,967       GLOBAL HEALTH PROGRAMS
(3) VAYU INC
847 WILLOW RUN AIRPORT DR
YPSILANTI,MI48198 		46-5737909 N/A 10,000       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(4) JHPIEGO
1615 THAMES STREET SUITE 200
BALTIMORE,MD212313447 		23-7424444 501(C)(3) 15,000       GLOBAL HEALTH PROGRAMS
(5) TECHCHANGE INC
2001 13TH ST NW 2ND FLOOR
WASHINGTON,DC20009 		27-3358772 N/A 16,500       GLOBAL HEALTH PROGRAMS
(6) UNIVERSITY OF MIAMI
MED CAMPUS PO BOX 016960 M-859
MIAMI,FL33101 		59-0624458 501(C)(3) 17,108       ESSENTIAL MEDICINE
(7) UNIVERSITY OF MASSACHUSETTS
MEDICAL SCHOOL 55 LAKE AVE NORTH
WORCESTER,MA01655 		04-3167352 GOV 20,000       ESSENTIAL MEDICINE
(8) BENEVOLENT HEALTHCARE FOUNDATION DBA PROJECT CURE
10377 E GEDDES AVENUE SUITE 200
CENTENNIAL,CO80112 		84-1568566 501(C)(3) 28,597       GLOBAL HEALTH PROGRAMS
(9) MEDICAL CARE DEVELOPMENT INC
11 PARKWOOD DRIVE
AUGUSTA,ME04330 		01-6022787 501(C)(3) 28,973       GLOBAL HEALTH PROGRAMS
(10) ROSTROPOVICH-VISHNEVSKAYA FOUNDATION
1776 K STREET NW SUITE 700
WASHINGTON,DC20006 		52-1752473 501(C)(3) 29,244       ESSENTIAL MEDICINE
(11) UNIVERSITY OF SOUTH FLORIDA
4202 EAST FOWLER AVENUE ALN 147
TAMPA,FL33620 		59-3102112 GOV 29,628       ESSENTIAL MEDICINE
(12) AMREF HEALTH AFRICA INC
4 WEST 43RD STREET 2ND FLOOR
NEW YORK,NY10036 		13-1867411 501(C)(3) 33,772       GLOBAL HEALTH PROGRAMS
(13) SEATTLE CHILDREN'S HOSPITAL
PO BOX 5371 M/S RC-507
SEATTLE,WA981455005 		91-0564748 501(C)(3) 39,739       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(14) THE WILLIAM DAVIDSON INST AT THE UNIV OF MICHIGAN (WDI)
724 E UNIVERSITY AVE WYLY HALL
FIRST FLOOR
ANN ARBOR,MI48109 		38-3048086 501(C)(3) 42,923       GLOBAL HEALTH PROGRAMS
(15) PARSYL INC
3963 WALNUT STREET STE 200
DENVER,CO80205 		81-4027966 N/A 46,400       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(16) CARDNO EMERGING MARKETS
2107 WILSON BLVD STE 800
ARLINGTON,VA22201 		52-1788060 N/A 57,894       GLOBAL HEALTH PROGRAMS
(17) POPULATION SERVICES INT'L INC
1120 19TH ST NW STE 600
WASHINGTON,DC20036 		56-0942853 501(C)(3) 59,381       GLOBAL HEALTH PROGRAMS
(18) GHP SOLUTIONS LLC
220 EAST 42ND STREET SUITE 710
NEW YORK,NY10017 		06-1652595 N/A 61,474       GLOBAL HEALTH PROGRAMS
(19) SOLAR ELECTRIC LIGHT FUND
1612 K STREET NW SUITE 300
WASHINGTON,DC20006 		52-1701564 501(C)(3) 66,402       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(20) PAN AMERICAN HEALTH ORGANIZATION
525 23RD STREET NW
WASHINGTON,DC20037 		23-7072046 501(C)(3) 67,799       GLOBAL HEALTH PROGRAMS
(21) UNIVERSITY OF MARYLAND
PO BOX 41428
BALTIMORE,MD212036428 		52-6002033 501(C)(3) 69,971       ESSENTIAL MEDICINE
(22) THE UNIVERSITY OF TEXAS AT AUSTIN
110 INNER CAMPUS DRIVE STOP K5300
AUSTIN,TX78712 		74-6000203 GOV 80,000       ESSENTIAL MEDICINE
(23) OPENMRS INC
10425 COMMERCE DR STE 110
CARMEL,IN460327643 		45-5316647 501(C)(3) 88,500       GLOBAL HEALTH PROGRAMS
(24) HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC
6720-A ROCKLEDGE DRIVE STE 100
BETHESDA,MD20817 		52-1317896 501(C)(3) 89,999       ESSENTIAL MEDICINE
(25) BASIC HEALTH INTERNATIONAL INC
25 BROADWAY 10TH FLOOR
NEW YORK,NY10004 		20-3408717 501(C)(3) 93,074       GLOBAL HEALTH PROGRAMS
(26) THE ALBERT B SABIN VACCINE INSTITUTE INC
2175 K STREET NW SUITE 400
WASHINGTON,DC20037 		06-1389829 501(C)(3) 100,000       ESSENTIAL MEDICINE
(27) FOOD AND DRUG ADMINISTRATION
5600 FISHERS LN HFA-140 RM 11-40
ROCKVILLE,MD20857 		53-0196965 GOV 110,500       ESSENTIAL MEDICINE
(28) HEALTH ALLIANCE INTERNATIONAL
4534 11TH AVENUE NE
SEATTLE,WA98105 		94-3047981 501(C)(3) 118,329       GLOBAL HEALTH PROGRAMS
(29) QUALIS HEALTH
10700 MERIDIAN AVE N SUITE 100
SEATTLE,WA98133 		91-1072875 501(C)(3) 127,144       GLOBAL HEALTH PROGRAMS
(30) KYBELE INC
3524 YADKINVILLE ROAD 124
WINSTONSALEM,NC27106 		90-0759003 501(C)(3) 133,219       GLOBAL HEALTH PROGRAMS
(31) MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02139 		04-2103594 501(C)(3) 140,000       ESSENTIAL MEDICINE
(32) UNIVERSITY OF VERMONT AND STATE
AGRICULTURAL COLLEGE 85 SOUTH
PROSPECT STREET
BURLINGTON,VT05405 		03-0179440 501(C)(3) 141,493       ESSENTIAL MEDICINE
(33) ACESO GLOBAL
1400 16TH STREET NW SUITE 430
WASHINGTON,DC20036 		47-4215911 501(C)(3) 145,548       GLOBAL HEALTH PROGRAMS
(34) HJF MEDICAL RESEARCH INTERNATIONAL INC
6720A ROCKLEDGE DRIVE SUITE 100
BETHESDA,MD20817 		52-2322791 501(C)(3) 136,117       GLOBAL HEALTH PROGRAMS
(35) HEIFER INTERNATIONAL DC
1 WORLD AVENUE
LITTLE ROCK,AR72202 		35-1019477 501(C)(3) 158,702       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(36) MASSACHUSETTS GENERAL HOSPITAL
ED ZERO EMERSON PL 104
BOSTON,MA02114 		04-1564655 501(C)(3) 175,000       ESSENTIAL MEDICINE
(37) ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION
AIDS FOUNDATION 1140 CONNECTICUT
AQG NW 200
WASHINGTON,DC20036 		95-4191698 501(C)(3) 223,762       GLOBAL HEALTH PROGRAMS
(38) SEATTLE BIOMEDICAL RESEARCH INSTITUTE
INSTITUTE 307 WESTLAKE AVE N SUITE
500
SEATTLE,WA981095219 		91-0961784 501(C)(3) 226,438       ESSENTIAL MEDICINE
(39) HARVARD UNIVERSITY
1033 MASSACHUSETTS AVE 2ND FLOOR
CAMBRIDGE,MA02115 		04-2103580 501(C)(3) 233,379       GLOBAL HEALTH PROGRAMS & ESSENTIAL MEDICINE
(40) TULANE UNIVERSITY
6823 ST CHARLES AQGE
NEW ORLEANS,LA70112 		72-0423889 501(C)(3) 235,475       GLOBAL HEALTH PROGRAMS
(41) THE STATE UNIVERSITY OF NEW ANORK
35 STATE STREET
ALBANY,NY122072826 		14-1368361 501(C)(3) 292,383       ESSENTIAL MEDICINE
(42) BRIGHAM & WOMEN'S HOSPITAL INC
651 HUNTINGTON AVE FXB BUILDING
BOSTON,MA02115 		04-2312909 501(C)(3) 302,658       GLOBAL HEALTH PROGRAMS
(43) CASCADE DESIGNS INC
4000 1ST AVE SOUTH
SEATTLE,WA98134 		91-0969695 N/A 315,000       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(44) FINA BIOSOLUTIONS LLC
9430 KEY WEST AVE SUITE 200
ROCKVILLE,MD20850 		20-5448275 N/A 321,231       ESSENTIAL MEDICINE
(45) HARVARD SCHOOL OF PUBLIC HEALTH
677 HUNTINGTON AVENUE
BOSTON,MA02215 		04-2103580 501(C)(3) 374,803       ESSENTIAL MEDICINE
(46) DUKE UNIVERSITY
BOX 104132
DURHAM,NC27708 		56-0532129 501(C)(3) 397,629       ESSENTIAL MEDICINE
(47) INITIATIVES INC
264 BEACON STREET
BOSTON,MA02116 		04-2961350 N/A 399,082       GLOBAL HEALTH PROGRAMS
(48) CINCINNATI CHILDREN'S HOSPITAL
MEDICAL CENTER 3333 BURNET AVE ML
6014
CINCINNATI,OH452293039 		31-0833936 501(C)(3) 415,954       ESSENTIAL MEDICINE
(49) US NAVAL MEDICAL RESEARCH
UNIT NO 3 NAMRU-3 503 ROBERT GRANT
AVE BLDG500
SILVER SPRING,MD20901 		47-0100048 GOV 434,441       ESSENTIAL MEDICINE
(50) RESULTS FOR DEVELOPMENT INSTITUTE INC
1100 15TH STREET NW SUITE 400
WASHINGTON,DC20005 		20-8530747 501(C)(3) 452,200       GLOBAL HEALTH PROGRAMS
(51) EHEALTH AFRICA
1200 G ST NW SUITE 800
WASHINGTON,DC20005 		81-4503438 501(C)(3) 482,335       GLOBAL HEALTH PROGRAMS
(52) POPULATION COUNCIL
ONE DAG HAMMERKJOLD PLAZA
NEW YORK,NY10017 		13-1687001 501(C)(3) 535,709       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(53) INTRAHEALTH INTERNATIONAL INC
6340 QUADRANGLE DRIVE SUITE 200
CHAPEL HILL,NC27517 		55-0825466 501(C)(3) 574,134       GLOBAL HEALTH PROGRAMS
(54) SYSTMAPP INC
2000 TOWN CENTER SUITE 300
SOUTHFIELD,MI48075 		81-2936844 N/A 600,000       GLOBAL HEALTH PROGRAMS
(55) VILLAGEREACH
2900 EASTLAKE AVE E SUITE 230
SEATTLE,WA981023012 		91-2088484 501(C)(3) 687,045       GLOBAL HEALTH PROGRAMS
(56) THE SCRIPPS RESEARCH INSTITUTE
10550 N TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 501(C)(3) 756,375       ESSENTIAL MEDICINE
(57) INVENTPRISE LLC
18133 NE 68TH STREET SUITE D 150
REDMOND,WA98052 		45-4927373 N/A 789,523       ESSENTIAL MEDICINE
(58) JOHNS HOPKINS UNIVERSITY
BLOOMBERG SCHL OF PUB HLTH 615 N
WOLFE STREET
BALTIMORE,MD21205 		52-0595110 501(C)(3) 831,856       GLOBAL HEALTH PROGRAMS & ESSENTIAL MEDICINE
(59) UNIVERSITY OF WASHINGTON
GRANT CONTRACT ACCOUNTING 12455
COLLECTIONS DRIVE
CHICAGO,IL60693 		91-6001537 501(C)(3) 1,225,899       GLOBAL HEALTH PROGRAMS, ESSENTIAL MEDICINE, & TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(60) BECTON DICKINSON & COMPANY
ONE BECTON DRIVE
FRANKLIN LAKES,NJ07417 		N/A 1,386,791       TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(61) NAT'L INST OF ALLERGY & INFECTIOUS DISEASES
6610 ROCKLEDGE DR ROOM 2800
BETHESDA,MD208926606 		52-0858115 GOV 1,387,280       ESSENTIAL MEDICINE
(62) JSI RESEARCH AND TRAINING INSTITUTE INC
1616 NORTH FORT MYER DR 16TH FLOOR
ARLINGTON,VA222093100 		04-2679824 N/A 1,390,705       GLOBAL HEALTH PROGRAMS
(63) WALTER REED ARMY INSTITUTE OF RESEARCH
US TREASURY 503 ROBERT GRANT AVE
SILVER SPRING,MD20910 		52-0664528 GOV 2,994,916       ESSENTIAL MEDICINE
(64) YALE UNIVERSITY
GRANT AND CONTRACT FINANCIAL ADMIN
PO BOX 1873
NEW HAVEN,CT065081873 		06-0646973 501(C)(3) -182,082       ESSENTIAL MEDICINE
(65) WORLD VISION
PO BOX 9716 DPTW
FEDERAL WAY,WA980639716 		95-1922279 501(C)(3) -86,473       GLOBAL HEALTH PROGRAMS
(66) HELEN KELLER INTERNATIONAL INC
352 PARK AVENUE SOUTH FLOOR 12
NEW YORK,NY10010 		13-5562162 501(C)(3) -18,449       GLOBAL HEALTH PROGRAMS
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
51
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
12
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2018

Schedule I (Form 990) 2018
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Number of
recipients		 (c) Amount of
cash grant		 (d) Amount of
noncash assistance		 (e) Method of valuation (book,
FMV, appraisal, other)		 (f) Description of noncash assistance
(1) GRANT 1 9,313      
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Part IV
Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.
Return Reference Explanation
PART I, LINE 2: PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.
Schedule I (Form 990) 2018



Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2018
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........
1b
Yes
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..
2
Yes
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
 
No
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2018

Schedule J (Form 990) 2018
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation 		(ii) Bonus & incentive
compensation 		(iii) Other reportable compensation
1STEPHEN B DAVIS
PRESIDENT AND CEO 		(i)

(ii)		 512,010
-------------
0 		152,067
-------------
0 		1,800
-------------
0 		32,200
-------------
0 		30,580
-------------
0 		728,657
-------------
0 		0
-------------
0
2OLIVIA D POLIUS
CHIEF FINANCIAL OFFICER 		(i)

(ii)		 318,546
-------------
0 		0
-------------
0 		2,100
-------------
0 		32,400
-------------
0 		19,536
-------------
0 		372,582
-------------
0 		0
-------------
0
3DANIEL LASTER
COO AND GENERAL COUNSEL 		(i)

(ii)		 308,869
-------------
0 		0
-------------
0 		1,800
-------------
0 		32,400
-------------
0 		9,144
-------------
0 		352,213
-------------
0 		0
-------------
0
4DAVID C KASLOW
VP - PRODUCT DEVELOPMENT 		(i)

(ii)		 377,245
-------------
0 		0
-------------
0 		1,800
-------------
0 		32,400
-------------
0 		33,278
-------------
0 		444,723
-------------
0 		0
-------------
0
5AMIE E BATSON
CHIEF STRATEGY OFFICER 		(i)

(ii)		 194,527
-------------
0 		0
-------------
0 		183,623
-------------
0 		21,347
-------------
0 		1,230
-------------
0 		400,727
-------------
0 		0
-------------
0
6KATHY CAHILL
VP - INTERNATIONAL DEVELOPMENT 		(i)

(ii)		 195,454
-------------
0 		0
-------------
0 		149,559
-------------
0 		23,454
-------------
0 		3,166
-------------
0 		371,633
-------------
0 		0
-------------
0
7DAVID W FLEMING
VP - PUBLIC HEALTH IMPACT 		(i)

(ii)		 286,869
-------------
0 		0
-------------
0 		0
-------------
0 		32,400
-------------
0 		18,211
-------------
0 		337,480
-------------
0 		0
-------------
0
8KATHRYN A O'DRISCOLL
CHIEF HUMAN RESOURCES OFFICER 		(i)

(ii)		 152,146
-------------
0 		0
-------------
0 		127,674
-------------
0 		18,452
-------------
0 		9,262
-------------
0 		307,534
-------------
0 		0
-------------
0
9ERICA J SESSLE
CHIEF OF STAFF 		(i)

(ii)		 212,878
-------------
0 		0
-------------
0 		1,500
-------------
0 		23,510
-------------
0 		11,224
-------------
0 		249,112
-------------
0 		0
-------------
0
10PRAVEEN RAJA
VP - TECH. DEV. & INNOVATION 		(i)

(ii)		 332,163
-------------
0 		0
-------------
0 		840
-------------
0 		20,239
-------------
0 		11,173
-------------
0 		364,415
-------------
0 		0
-------------
0
11ELAINE L GIBBONS
VP - GLOBAL ENGAGEMENT 		(i)

(ii)		 264,986
-------------
0 		0
-------------
0 		840
-------------
0 		32,400
-------------
0 		33,413
-------------
0 		331,639
-------------
0 		0
-------------
0
12JEFFREY D BERSON
ASSOCIATE DIRECTOR II 		(i)

(ii)		 170,197
-------------
0 		0
-------------
0 		261,254
-------------
0 		24,555
-------------
0 		57,549
-------------
0 		513,555
-------------
0 		0
-------------
0
13JAMES B MCKENNA
ASSOCIATE DIRECTOR II 		(i)

(ii)		 141,788
-------------
0 		0
-------------
0 		254,520
-------------
0 		21,650
-------------
0 		53,582
-------------
0 		471,540
-------------
0 		0
-------------
0
14TRAD M HATTON
CHIEF OF PARTY 		(i)

(ii)		 134,488
-------------
0 		0
-------------
0 		186,718
-------------
0 		17,173
-------------
0 		31,611
-------------
0 		369,990
-------------
0 		0
-------------
0
15BRUCE LAMONT INNIS
GLOBAL DISEASE AREA HEAD 		(i)

(ii)		 310,536
-------------
0 		0
-------------
0 		840
-------------
0 		27,312
-------------
0 		-667
-------------
0 		338,021
-------------
0 		0
-------------
0
16JOHN O KONZ
GLOBAL INT. PORT/FIN MGMT. CVIA HEAD 		(i)

(ii)		 298,375
-------------
0 		0
-------------
0 		840
-------------
0 		32,400
-------------
0 		32,203
-------------
0 		363,818
-------------
0 		0
-------------
0
Schedule J (Form 990) 2018

Schedule J (Form 990) 2018
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
PART I, LINE 1A HOUSING ALLOWANCES & TAX INDEMNIFICATIONS ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITIONS. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT.
PART I, LINE 4A THE FOLLOWING EMPLOYEES RECEIVED SEVERANCE PAYMENTS IN 2018: - KATHRYN A. O'DRISCOLL $126,624 - AMIE BATSON $162,501 - KATHY CAHILL $143,503
PART I, LINE 7 BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).
Schedule J (Form 990) 2018
Additional Data


Software ID:  
Software Version:  
SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
Noncash Contributions
Right pointing arrow large imageComplete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
Right pointing arrow large imageGo to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2018
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of contributions or items contributed 		(c)
Noncash contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
noncash contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 19 242,558 FMV
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ...        
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( SUPPLIES ) X 3 17,356 COST
26 Other Right pointing arrow large image ( )
27 Other Right pointing arrow large image ( )
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement
29
0
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which is not required to be used for exempt purposes for the entire holding period? ...................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash
contributions? ..........................
32a
 
No
b
If "Yes," describe in Part II.
33
If the organization did not report an amount in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) (2018)
Schedule M (Form 990) (2018)
Page 2
Part II
Supplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.
Return Reference Explanation
PART I, COLUMN (B): THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS.
Schedule M (Form 990) (2018)

Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2018
Open to Public
Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Return Reference Explanation
FORM 990, PART I, LINE 1 PATH IS A GLOBAL ORGANIZATION THAT WORKS TO ACCELERATE HEALTH EQUITY BY BRINGING TOGETHER PUBLIC INSTITUTIONS, BUSINESSES, SOCIAL ENTERPRISES, AND INVESTORS TO SOLVE THE WORLD'S MOST PRESSING HEALTH CHALLENGES. WITH EXPERTISE IN SCIENCE, HEALTH, ECONOMICS, TECHNOLOGY, ADVOCACY, AND DOZENS OF OTHER SPECIALTIES, PATH DEVELOPS AND SCALES SOLUTIONS-INCLUDING VACCINES, DRUGS, DEVICES, DIAGNOSTICS, AND INNOVATIVE APPROACHES TO STRENGTHENING HEALTH SYSTEMS WORLDWIDE. SINCE 2011, PATH AND OUR PARTNERS AND SUPPORTERS HAVE REACHED AN AVERAGE OF MORE THAN 150 MILLION PEOPLE EACH YEAR WITH LIFESAVING HEALTH SOLUTIONS.
FORM 990, PART III, LINE 4A PATH CONTINUED TO PILOT INNOVATIONS TO REACH MOST-AT-RISK POPULATIONS IN VIETNAM. WE EQUIPPED SOCIAL AND SUPPORT GROUPS OPERATED BY MEMBERS OF KEY POPULATIONS TO GENERATE DEMAND FOR SERVICES AMONG THEIR PEERS THROUGH TARGETED OUTREACH VIA SOCIAL MEDIA, LINKAGES TO HIV TESTING SERVICES THROUGH MOBILE APPLICATIONS, AND SCALE-UP OF HIV SELF-TESTING AND PREP. PATH ALSO ENGAGED THE GOVERNMENT OF VIETNAM TO INTRODUCE NEW MODELS OF HIV TESTING, INCLUDING EXPANDING ACCESS TO HIV LAY- AND SELF-TESTING AND PARTNER NOTIFICATION SERVICES, INTRODUCING AND SCALING FEE-BASED PREP, LAUNCHING THREE LOCAL CONDOM BRANDS MARKETED FOR KEY POPULATIONS, AND DEVELOPING BETTER LOW-DEAD-SPACE SYRINGES FOR PEOPLE WHO INJECT DRUGS. PATH ALSO BRINGS GLOBAL HEALTH EXPERTISE AND INNOVATIVE APPROACHES TO THE FIGHT AGAINST TB. WE WORK DIRECTLY WITH PUBLIC- AND PRIVATE-SECTOR LABORATORIES TO STRENGTHEN CAPACITY TO QUICKLY DIAGNOSE DRUG-SUSCEPTIBLE, MULTIDRUG-RESISTANT, AND EXTENSIVELY DRUG-RESISTANT TB PATIENTS. WE ALSO SUPPORT FACILITIES AND LABORATORIES WITH INFRASTRUCTURE, SUCH AS SOLAR PANELS AND COMPUTER SYSTEMS, TO RUN TB DIAGNOSTIC EQUIPMENT AND ENSURE A SUSTAINABLE PLAN FOR MAINTENANCE AND CARE. IN UKRAINE, PATH LED THE USAID-FUNDED SERVING LIFE PROJECT, WORKING TO REDUCE TB, HIV, AND HEPATITIS C TRANSMISSION IN PRE-TRIAL DETENTION CENTERS, PRISONS, POST-PRISON SETTINGS, AND THE COMMUNITY. STRATEGIES INCLUDED INCREASING CASE DETECTION, STRENGTHENING LINKAGES TO CARE, AND EMPLOYING A CASE-MANAGEMENT APPROACH TO ENSURE THAT INSTITUTIONALIZED OR COMMUNITY-BASED KEY POPULATIONS WHO HAVE TB, HIV, OR HEPATITIS C CAN COMPLETE TREATMENT. IN A RELATED EFFORT, PATH PARTNERED WITH THE MINISTRY OF JUSTICE TO ENSURE THAT ALL NEWLY INCARCERATED INDIVIDUALS ARE ROUTINELY SCREENED FOR TB UPON ENTRY, ANNUALLY, AND PRIOR TO RELEASE, AND THAT THOSE CONFIRMED WITH ACTIVE TB RECEIVE TREATMENT DURING INCARCERATION OR A REFERRAL TO A TB TREATMENT FACILITY AFTER RELEASE. UNDER THE USAID-FUNDED ERADICATE TB PROJECT IN ZAMBIA, PATH ENGAGED DIRECTLY WITH PRISON ADMINISTRATORS TO PROMOTE TB SCREENING UPON ENTRY, ANNUALLY, AND PRIOR TO RELEASE. IN TANZANIA, UNDER THE CHALLENGE TB PROJECT, PATH STRENGTHENED THE CAPACITY OF SIX CIVIL-SOCIETY ORGANIZATIONS TO PROVIDE COMMUNITY-BASED TB TREATMENT ADHERENCE SUPPORT. PATH ALSO DEVELOPED A TREATMENT ADHERENCE APP THAT SENDS TREATMENT AND APPOINTMENT REMINDERS TO PEOPLE WITH TB VIA TEXT MESSAGE. AFTER ITS LAUNCH IN SEPTEMBER 2018, MORE THAN 7,500 PEOPLE ENROLLED IN THE APP. IN ADDITION, PATH DEVELOPED AND LAUNCHED A SELF-SCREENING APP TO RAISE AWARENESS ABOUT TB AND INCREASE TB CASE DETECTION. THOSE WHO SELF-REPORT AS PRESUMPTIVE FOR TB RECEIVE REFERRAL MESSAGES TO GO TO A NEARBY HEALTH FACILITY FOR CONFIRMATORY TESTING. IN INDIA, WE CONTINUED TO IMPLEMENT THE PUBLIC-PRIVATE INTERFACE AGENCY (PPIA) PROJECT TO IMPROVE PRIVATE HEALTH CARE PROVIDERS' CONTRIBUTIONS TO TB CONTROL ACROSS 15 WARDS IN THE URBAN SLUMS OF MUMBAI. IN 2018, THE PROJECT FURTHER ENGAGED WITH FORMAL AND INFORMAL PRACTITIONERS, LABORATORIES, CHEMISTS, AND HOSPITALS TO PROVIDE STANDARDIZED TB DIAGNOSIS AND TREATMENT SERVICES. PATH ALSO SUPPORTED A VOUCHER MECHANISM TO CONNECT PATIENTS FROM LOCAL INFORMAL PROVIDERS TO QUALIFIED PHYSICIANS, DIAGNOSTIC SERVICES, AND TREATMENT SUPPORT. THE PROJECT HAS DRAMATICALLY IMPROVED ACCESS TO TB SERVICES. THE BREATH FOR LIFE PROJECT IN VIETNAM DEVELOPED AND TESTED A MODEL THAT ADDRESSES HEALTH SYSTEM CHALLENGES CONTRIBUTING TO LOW DETECTION OF TB AMONG CHILDREN. OUR EFFORTS THROUGH THIS PROJECT RESULTED IN DECENTRALIZED PEDIATRIC TB DIAGNOSIS AND TREATMENT, A DOUBLING OF TB DIAGNOSIS AMONG CHILDREN, AND A FOURFOLD INCREASE IN ELIGIBLE CHILDREN ON TB PREVENTIVE THERAPY. BUILDING ON OUR PEDIATRIC WORK UNDER BREATH FOR LIFE, PATH COORDINATED WITH THE ZAMBIA MINISTRY OF HEALTH IN 2018 TO FINALIZE CHILDHOOD TB TRAINING MATERIALS. MEASUREMENT AND LEARNING CONTINUED TO SERVE AS CORNERSTONES FOR PATH'S TB PROGRAMMING. UNDER THE ERADICATE TB PROJECT IN ZAMBIA, PATH COORDINATED WITH THE MINISTRY OF HEALTH AND NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAM TO UPDATE THEIR MONITORING SYSTEMS, INCLUDING SECONDING A MONITORING AND EVALUATION (M&E) ADVISOR WHO PROVIDES ON-SITE MENTORSHIP TO NATIONAL-LEVEL GOVERNMENT OFFICIALS TO ANALYZE DATA FOR PROGRAMMATIC DECISION-MAKING. IN INDIA, PATH DEVELOPED M&E AND REPORTING GUIDELINES FOR PUBLIC-PRIVATE MIX NETWORKS AND PROVIDED DIRECT TECHNICAL ASSISTANCE TO THE GOVERNMENT TO STRENGTHEN CAPACITY IN DATA ANALYSIS AND USE. IN VIETNAM, PATH HELPED THE MINISTRY OF HEALTH TO INTEGRATE PUBLIC-PRIVATE MIX AND PEDIATRIC TB DATA-CAPTURE INTO NATIONAL M&E SYSTEMS. MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION PATH WORKS WITH PARTNERS TO IMPROVE MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION AROUND THE WORLD. TOGETHER WE DEVELOP, ADAPT, AND SCALE TECHNOLOGIES AND APPROACHES TO REDUCE ILLNESS AND DEATH AND GIVE CHILDREN THE BEST POSSIBLE START IN LIFE. IN ALL OUR EFFORTS, WE PUT THE LOCAL GOVERNMENT IN THE DRIVER'S SEAT TO ENSURE BOTH SCALE AND SUSTAINABILITY. IN 2018, PATH CONTINUED TO EXPAND OUR GLOBAL AND NATIONAL LEADERSHIP IN EARLY CHILDHOOD DEVELOPMENT (ECD). WITH PATH'S SUPPORT, THE GOVERNMENTS OF ETHIOPIA, KENYA, MOZAMBIQUE, AND ZAMBIA INCORPORATED ECD SERVICES INTO BASIC HEALTH CARE FOR CAREGIVERS AND YOUNG CHILDREN. ALONG WITH WHO, UNICEF, THE WORLD BANK, AND OTHERS, PATH ALSO CONTRIBUTED TO THE DEVELOPMENT, LAUNCH, AND INTRODUCTION OF THE NURTURING CARE FOR ECD FRAMEWORK, WHICH SETS THE STRUCTURE FOR COUNTRIES TO ADOPT, ADAPT, AND SCALE ECD SERVICES. PATH'S PIONEERING WORK TO INTEGRATE ECD INTO HEALTH SYSTEMS HAS FOCUSED ON BUILDING AN ENABLING LEADERSHIP AND POLICY ENVIRONMENT WHILE SUPPORTING AND BUILDING THE CAPACITY OF EXISTING HEALTH SERVICE SYSTEMS AND PROVIDERS AT BOTH THE FACILITY AND COMMUNITY LEVELS AND STRENGTHENING REFERRAL SYSTEMS. PATH ALSO CONTINUED EFFORTS TO ENSURE THAT ALL INFANTS RECEIVE HUMAN MILK. OUR EFFORTS CENTER AROUND AN INTEGRATED MODEL FOR BREASTFEEDING PROMOTION, INCLUDING THE PROVISION OF SAFE DONOR MILK THROUGH HUMAN MILK BANKS. PATH DEVELOPED STRENGTHENING HUMAN MILK BANKING: A RESOURCE TOOLKIT FOR ESTABLISHING AND OPERATING HUMAN MILK BANK PROGRAMS, THE FIRST-EVER STANDARD TO ENSURE QUALITY AND SAFETY. PATH CONTINUED TO ADVOCATE FOR POLICIES TO GUIDE APPROPRIATE AND ETHICAL USE OF DONOR HUMAN MILK, WORKING WITH GLOBAL TECHNICAL AND POLICY LEADERS TO DRIVE SCALE-UP. PATH WORKED WITH THE KENYA MINISTRY OF HEALTH TO PREPARE FOR THE LAUNCH OF THE FIRST HUMAN MILK BANK IN THE EAST AFRICAN REGION. IN GHANA, THE MAKING EVERY BABY COUNT INITIATIVE STRENGTHENS LEADERSHIP AND CAPACITY AT THE NATIONAL AND LOCAL LEVELS TO MANAGE AND SUSTAIN BEST PRACTICES IN NEWBORN CARE. IN 2018, PATH SUPPORTED GHANA'S CENTRAL GOVERNMENT AND REGIONS TO REDUCE NEONATAL MORTALITY THROUGH SPECIFIC ACTIVITIES THAT IMPROVED AND STANDARDIZED NEWBORN CARE. RECOGNIZING THAT NUTRITION IS AFFECTED BY A VARIETY OF ECONOMIC AND ENVIRONMENTAL FACTORS, PATH'S NUTRITION TEAM CONTINUED TO DRIVE NOVEL APPROACHES TO ADDRESS THE MASSIVE BURDEN OF MALNUTRITION IN COMMUNITIES AROUND THE WORLD. WE ENGAGED STAKEHOLDERS WITH EXPERTISE SPANNING GLOBAL HEALTH, DEVELOPMENT, AND THE ENVIRONMENT, FROM BOTH THE PUBLIC AND PRIVATE SECTORS. IN ADDITION, PATH CONTINUED TO SUPPORT A PROJECT KNOWN AS MAXIMIZING THE QUALITY OF SCALING UP NUTRITION PLUS (MQSUN+). IN THIS PROJECT, PATH LEADS A CONSORTIUM OF FIVE ORGANIZATIONS THAT ARE EXPANDING THE EVIDENCE BASE ON THE CAUSES OF UNDERNUTRITION, ENHANCING THE SKILLS AND CAPACITY OF PARTICIPATING GOVERNMENTS TO SCALE UP NUTRITION-RELATED PROGRAMS AND POLICIES, AND PROVIDING TECHNICAL GUIDANCE ON PROGRAM DESIGN, IMPLEMENTATION, AND M&E. OTHER NUTRITION-RELATED ACTIVITIES IN 2018 INCLUDED COLLABORATION WITH THE NATURE CONSERVANCY, DUKE UNIVERSITY, AND THE INTERNATIONAL FOOD POLICY RESEARCH INSTITUTE TO ADVANCE THE USE OF ALTERNATIVE PROTEINS; THIS WORK WAS FUNDED BY THE ROCKEFELLER FOUNDATION. IN INDIA, WE EXPANDED OUR FORTIFIED RICE SCHOOL FEEDING PROGRAM IN KARNATAKA AND GUJARAT STATES. WE CONTINUED TO DRIVE MULTISECTORAL COLLABORATION IN 2018 BY FURTHERING THE BRIDGE COLLABORATIVE, A TRAILBLAZING, CROSS-DISCIPLINARY EFFORT TO ENGAGE MORE THAN 150 LEADING TECHNICAL EXPERTS FROM THE HEALTH, DEVELOPMENT, AND ENVIRONMENTAL SECTORS TO ADDRESS HUMAN AND PLANETARY HEALTH. WE PUBLISHED SEVERAL PEER-REVIEWED PAPERS AND HELD SEVERAL HIGH-LEVEL MEETINGS ON THE INTERSECTION OF HUMAN AND PLANETARY HEALTH IN CONJUNCTION WITH THE UNITED NATIONS DEVELOPMENT PROGRAM. IN 2018, SEVERAL PATH STAFF MEMBERS PRESENTED AT KEY GLOBAL AND NATIONAL MEETINGS, EMPHASIZING OUR GLOBAL THOUGHT-LEADERSHIP. PATH STAFF ALSO AUTHORED, EDITED, AND CONTRIBUTED TO VARIOUS HIGH-PROFILE PEER-REVIEWED JOURNAL ARTICLES, BOOK CHAPTERS, GLOBAL REPORTS, AND SYSTEMATIC REVIEWS. THESE EFFORTS ADVANCED THINKING ON BROAD, EFFECTIVE SOLUTIONS TO DEEPLY CHALLENGING MATERNAL,
FORM 990, PART III, LINE 4A NEWBORN, AND CHILD HEALTH AND NUTRITION PROBLEMS. SEXUAL AND REPRODUCTIVE HEALTH PATH'S WORK IN SEXUAL AND REPRODUCTIVE HEALTH IS GUIDED BY THE KEY PRINCIPLES OF CHOICE, EQUITY, AND DIGNITY FOR ALL WOMEN. BECAUSE WE UNDERSTAND THE COMPLEX SOCIAL, BEHAVIORAL, AND GENDER DIMENSIONS OF WOMEN'S REPRODUCTIVE HEALTH, WE BUILD EVIDENCE AROUND TOOLS AND SERVICES THAT ARE BEST SUITED TO ADDRESS WOMEN'S DIVERSE NEEDS AND CIRCUMSTANCES. WE SPECIALIZE IN REDUCING BARRIERS TO ACCESS. PATH CONTINUES TO CHAMPION THE RIGHT OF WOMEN TO MANAGE THEIR OWN SEXUAL AND REPRODUCTIVE HEALTH NEEDS BY CREATING AND ADVANCING IMPROVED TOOLS AND PRACTICES THAT MAKE WOMEN'S SELF-CARE POSSIBLE. AN INTEGRATED APPROACH TO WOMEN'S HEALTH INCLUDES ATTENTION TO CONTRACEPTION, CERVICAL AND BREAST CANCER, SEXUALLY TRANSMITTED INFECTIONS, THE RIGHT TO DECIDE WHETHER AND WHEN TO BECOME A MOTHER, AND GENDER-BASED VIOLENCE PREVENTION AND CARE SERVICES. WE SPEARHEAD DISCUSSIONS ON THE PRACTICES, BEHAVIORS, AND TOOLS THAT ENABLE WOMEN TO SELF-ASSESS AND SELF-MANAGE THEIR SEXUAL AND REPRODUCTIVE HEALTH NEEDS. AMONG THE RECENT WOMAN-INITIATED PRODUCTS INTRODUCED BY PATH ARE AN ALL-IN-ONE INJECTABLE CONTRACEPTIVE THAT CAN BE SELF-ADMINISTERED AND A VAGINAL SELF-SAMPLING KIT FOR HUMAN PAPILLOMAVIRUS (HPV) TESTING IN CERVICAL CANCER SCREENING PROGRAMS, AS DESCRIBED BELOW. PATH'S RESEARCH AND COORDINATION TO EXPAND ACCESS TO THE INJECTABLE CONTRACEPTIVE SUBCUTANEOUS DMPA (DMPA-SC, OR SAYANA PRESS) CONTINUED IN 2018, PRIMARILY THROUGH THE SELF-INJECTION BEST PRACTICES AND ACCESS COLLABORATIVE PROJECTS. THE SELF-INJECTION PROJECT IN UGANDA LAUNCHED TO GATHER INFORMATION ABOUT HOW THE PRACTICE CAN BE DESIGNED AND IMPLEMENTED AT SCALE. BY THE END OF 2018, AT LEAST 7,000 WOMEN WERE SELF-INJECTING ACROSS FOUR DISTRICTS THROUGH THIS PROGRAM. THE DMPA-SC ACCESS COLLABORATIVE WORKS WITH MINISTRIES OF HEALTH AND PARTNERS ACROSS SECTORS IN TEN COUNTRIES TO FACILITATE DMPA-SC COUNTRY INTRODUCTION AND SCALE-UP PLANNING FOR A RANGE OF CONTRACEPTIVE OPTIONS. IN 2018, THE COLLABORATIVE PROVIDED TECHNICAL ASSISTANCE TO ENSURE IMPLEMENTATION OF EACH COUNTRY'S TOTAL MARKET PLAN. FURTHERMORE, THE COLLABORATIVE FACILITATED LEARNING ACROSS COUNTRIES BY EXCHANGING INFORMATION, RESULTS, AND LESSONS LEARNED; TROUBLESHOOTING CHALLENGES; AND ACCELERATING THE ADOPTION OF BEST PRACTICES. PATH ALSO WORKED WITH PARTNERS WORLDWIDE AND IN SEVERAL COUNTRIES TO IMPROVE THE PREVENTION, DETECTION, AND TREATMENT OF CERVICAL PRECANCER, WHICH IS CAUSED BY INFECTION WITH HPV. WE CONTINUED OUR PARTNERSHIP WITH THE MINISTRIES OF HEALTH IN GUATEMALA, HONDURAS, AND NICARAGUA TO SUPPORT THE SCALE-UP OF HPV TESTING IN THE PUBLIC-SECTOR HEALTH SYSTEM. WE PROVIDED TECHNICAL SUPPORT FOR PROCUREMENT OF TESTS, SUPPORTED ADVOCACY AND DISSEMINATION EVENTS AT THE MINISTRIES OF HEALTH, AND MADE PROGRESS TOWARD TRANSITIONING LEADERSHIP OF THE PROGRAM TO THE MINISTRIES THEMSELVES AS THE PROJECT BEGAN ITS FINAL YEAR. WE DEDICATED ADDITIONAL EFFORTS TO EVALUATING FOLLOW-UP AND TREATMENT STRATEGIES TO ENSURE WOMEN RECEIVE APPROPRIATE CARE DURING EACH STAGE OF A COMPREHENSIVE CERVICAL CANCER PREVENTION PROGRAM. IN MYANMAR, WE ENGAGED WITH THE MINISTRY OF HEALTH AND OTHER STAKEHOLDERS TO DESIGN AN OPERATIONAL PLAN FOR CERVICAL CANCER CONTROL. PATH EXPERTS ALSO PARTICIPATED ACTIVELY IN WHO'S CALL FOR GLOBAL CERVICAL CANCER ELIMINATION BY ATTENDING INTERNATIONAL MEETINGS TO DEFINE ELIMINATION TARGETS AND SHAPE STRATEGIES FOR LOW- AND MIDDLE-INCOME COUNTRIES. TO COMBAT BREAST CANCER, WE WORKED WITH THE NATIONAL CANCER INSTITUTE IN PERU AND OTHER REGIONAL STAKEHOLDERS TO IMPLEMENT A MODEL FOR EARLY DETECTION OF BREAST CANCER THAT IS APPROPRIATE AND FEASIBLE FOR LOW- AND MIDDLE-RESOURCE SETTINGS. WE BUILT THE CAPACITY OF NUMEROUS HEALTH PROFESSIONALS TO IMPLEMENT THIS MODEL AND CONDUCTED ADVOCACY ACTIVITIES AMONG HEALTH OFFICIALS TO ENSURE BREAST CANCER STAYS ON THE AGENDA AND WOMEN RECEIVE SCREENING AND TREATMENT EVEN IN THE ABSENCE OF MAMMOGRAPHY SERVICES. PATH ALSO CONTINUED TO SERVE AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION. THIS IS A GLOBAL PARTNERSHIP OF MORE THAN 400 PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCY AND SEXUALLY TRANSMITTED INFECTIONS. NONCOMMUNICABLE DISEASES PATH IS AT THE FOREFRONT OF THE FIGHT IN LOW- AND MIDDLE-INCOME COUNTRIES AGAINST NONCOMMUNICABLE DISEASES (NCDS), INCLUDING DIABETES, CARDIOVASCULAR DISEASE, AND WOMEN'S CANCERS. THESE DISEASES ARE RESPONSIBLE FOR TWO-THIRDS OF DEATHS WORLDWIDE, AND ALMOST 75 PERCENT OF THESE DEATHS OCCUR IN LOWER-RESOURCE SETTINGS. IN 2018, PATH CONTINUED TO EXPAND OUR NCD PROGRAM. THROUGH THIS PROGRAM, PATH SERVES AS THE SECRETARIAT OF THE COALITION FOR ACCESS TO NCD MEDICINES & PRODUCTS, WHICH WAS LAUNCHED IN 2017. THIS GLOBAL, MULTISECTORAL COALITION IS DEDICATED TO INCREASING ACCESS TO NCD MEDICINES AND HEALTH PRODUCTS IN LOW- AND MIDDLE-INCOME COUNTRIES. MEMBERS INCLUDE GOVERNMENT AGENCIES, PRIVATE-SECTOR ENTITIES, NONGOVERNMENTAL ORGANIZATIONS, PHILANTHROPIC FOUNDATIONS, AND ACADEMIC INSTITUTIONS. IN ADDITION TO ITS GLOBAL ADVOCACY EFFORTS, THE COALITION BEGAN IMPLEMENTATION ACTIVITIES IN EAST AFRICA, STARTING WITH KENYA AND UGANDA, FOCUSING ON SUPPLY CHAIN STRENGTHENING, LANDSCAPING, AND A COSTING STUDY. IN KENYA, PATH CONTINUED TO IMPLEMENT A FIRST-OF-ITS-KIND PROGRAM THAT INTEGRATES SCREENING AND CARE FOR HYPERTENSION INTO HIV/AIDS SERVICES. THE PROGRAM WAS IN FULL IMPLEMENTATION IN 2018, WITH 51 PARTICIPATING FACILITIES. FURTHERMORE, IN PARTNERSHIP WITH KENYA'S MINISTRY OF HEALTH, PATH LAUNCHED THE NCD NAVIGATOR (PREVIOUSLY CALLED THE GLOBAL ASSESSMENT FRAMEWORK) TO MAP NCD INITIATIVES IN KENYA AND INFORM STRATEGIC PLANNING EFFORTS, IDENTIFY GAPS AND AREAS OF OVERLAP, AND SUPPORT GREATER ALIGNMENT WITH THE NATIONAL STRATEGY. IN SENEGAL, IN COLLABORATION WITH INTRAHEALTH AND THE MINISTRY OF HEALTH AND SOCIAL ACTION, PATH IMPLEMENTED THE BETTER HEARTS BETTER CITIES PROJECT. THE PROJECT'S AMBITIOUS AIM IS TO IMPROVE THE HYPERTENSION CONTROL RATE IN DAKAR. IN VIETNAM, PATH IMPLEMENTED THE COMMUNITIES FOR HEALTHY HEARTS PROJECT TO IMPROVE BLOOD PRESSURE CONTROL AMONG ADULTS BY INCREASING ACCESS TO AND USE OF HIGH-QUALITY HYPERTENSION SERVICES THAT ARE SUSTAINABLE AND SCALABLE. THE PROJECT DIRECTLY BENEFITS 700,000 PEOPLE IN FOUR DISTRICTS IN HO CHI MINH CITY. BY THE END OF 2018, NEARLY 33 PERCENT OF PEOPLE SCREENED WERE FOUND TO HAVE HIGH BLOOD PRESSURE MEASUREMENTS AND WERE REFERRED FOR HYPERTENSION DIAGNOSIS, TREATMENT, AND MANAGEMENT (IF REQUIRED). PATH IS ALSO IMPLEMENTING A PROJECT FOCUSED ON HYPERTENSION SCREENING IN URBAN SLUMS IN MUMBAI, INDIA, IN PARTNERSHIP WITH RESOLVE TO SAVE LIVES. THE PROJECT USES A PRIVATE-SECTOR ENGAGEMENT MODEL TO IMPROVE HYPERTENSION SCREENING, DIAGNOSIS, AND CARE. IN ADDITION, PATH LED AND CONTRIBUTED TO CONVENINGS TO RAISE AWARENESS OF NCDS AND ORCHESTRATE ACTION TO IMPROVE ACCESS TO PREVENTION AND CARE FOR PEOPLE AT RISK FOR OR LIVING WITH THESE DISEASES. HEALTH SYSTEMS INNOVATION AND DELIVERY PATH'S HEALTH SYSTEMS INNOVATION AND DELIVERY PROGRAM IMPROVES THE HEALTH AND WELL-BEING OF PEOPLE IN LOW- AND MIDDLE-INCOME COUNTRIES BY STRENGTHENING HEALTH SYSTEMS AND ENHANCING COUNTRY CAPACITY FOR DATA-DRIVEN DECISION-MAKING. OUR PORTFOLIO SERVES AS AN ORGANIZING MECHANISM FOR PATH PROJECTS, INITIATIVES, AND UNITS THAT STRENGTHEN HEALTH SYSTEMS. THE HEALTH SYSTEMS ANALYTICS UNIT PROMOTES SYSTEMS THINKING IN THE DESIGN, IMPLEMENTATION, SCALE-UP, AND EVALUATION OF HEALTH PROGRAMS AND TECHNOLOGIES. WITHIN AND OUTSIDE OF PATH, THIS UNIT LEADS COMPLEX EVALUATIONS, ENGAGES IN IMPLEMENTATION SCIENCE RESEARCH, FACILITATES HEALTH TECHNOLOGY INTRODUCTION AND SCALE-UP, AND WORKS TO IMPROVE DATA QUALITY AND USE FOR DECISION-MAKING. IN 2018, AS PART OF THE GLOBAL FUND'S PROSPECTIVE COUNTRY EVALUATIONS, THE UNIT CONTINUED EVALUATING THE GLOBAL FUND'S BUSINESS MODEL IN THE DRC, GUATEMALA, AND UGANDA USING A MIXED-METHODS APPROACH. STAFF ENGAGED IN SEVERAL NETWORK ANALYSES TO INFORM THE OPTIMAL STRUCTURE AND FUNCTION OF VARIOUS COALITIONS AND INFORMAL AND FORMAL NETWORKS. PATH STAFF CONTRIBUTED TECHNICAL EXPERTISE TO THE EXPANDED PROGRAM ON IMMUNIZATION'S LEADERSHIP AND MANAGEMENT PROGRAM, LED BY YALE UNIVERSITY AND FUNDED BY GAVI, THE VACCINE ALLIANCE. THE HEALTH SYSTEMS STRENGTHENING IMPACT TEAM CONTINUED TO SERVE AS A HUB FOR STAFF WORKING IN HEALTH SYSTEMS. THE GROUP CONVENED TO PLAN FOR FUTURE WORK IN STRENGTHENING URBAN HEALTH SYSTEMS, IMPROVING COMMUNITY-LEVEL DATA USE, AND DEVELOPING RESOURCES FOR SUCCESSFUL INTRODUCTION AND SCALE-UP OF INTERVENTIONS AND TECHNOLOGIES. THIS TEAM ALSO DEVELOPED PATH'S PRIMARY HEALTH CARE STRATEGY. THE GLOBAL HEALTH SECURITY TEAM CONTINUED TO INNOVATE SYSTEMS FOR THE PREVENTION, DETECTION, AND CONTROL OF INFECTIOUS DISEASE
FORM 990, PART III, LINE 4A OUTBREAKS. WITH SUPPORT FROM THE US CENTERS FOR DISEASE CONTROL AND PREVENTION, THE TEAM WORKED WITH NATIONAL LEADERS IN THE DRC, SENEGAL, TANZANIA, AND VIETNAM TO STRENGTHEN THEIR PUBLIC HEALTH SYSTEMS AND BUILD THEIR CAPACITY IN EPIDEMIC PREPAREDNESS AND RESPONSE. THE TEAM ALSO BEGAN WORK AS A MAJOR SUBGRANTEE UNDER ICF INTERNATIONAL FOR SURVEILLANCE ACTIVITIES IN THE USAID-SUPPORTED INFECTIOUS DISEASE DETECTION & SURVEILLANCE PROJECT. THIS PROJECT WORKS TO IMPROVE THE DETECTION OF HIGH-PRIORITY INFECTIOUS DISEASES AND IDENTIFICATION OF ANTIMICROBIAL RESISTANCE THROUGH IMPROVED DIAGNOSTIC AND SURVEILLANCE SYSTEMS. OUR CROSS-ORGANIZATIONAL IMPACT TEAM FOCUSING ON EPIDEMIC PREPAREDNESS AND RESPONSE CONTINUED TO BE AT THE FOREFRONT OF THE EBOLA RESPONSE IN THE DRC, PROVIDING A KEY ROLE IN SURVEILLANCE, DETECTION, AND RESOURCE MOBILIZATION. THE TEAM IS DEVELOPING AND INTRODUCING INNOVATIONS TO STRENGTHEN ELECTRONIC HEALTH INFORMATION SYSTEMS, ADVANCING NOVEL VACCINE PLATFORMS, PREPARING MEDICAL COUNTERMEASURES FOR PANDEMIC INFLUENZA, AND DEFINING PATH'S ROLE IN COMBATING ANTIMICROBIAL RESISTANCE. DIGITAL HEALTH SOLUTIONS PATH USES INFORMATION AND COMMUNICATION TECHNOLOGIES TO IMPROVE HEALTH AND SAVE LIVES. IN 2018, OUR GROWING DIGITAL HEALTH TEAM APPLIED ITS EXPERTISE TO SEVERAL PROJECTS. KEY ACCOMPLISHMENTS INCLUDED LAUNCHING THE WHO-PATH STRATEGIC COLLABORATION ON INNOVATION AND GLOBAL DIGITAL HEALTH. THIS COLLABORATION WILL BRING TOGETHER A CROSS-SECTOR NETWORK OF DIGITAL HEALTH EXPERTS AND INVESTORS TO SUPPORT WHO IN DEVELOPING A GLOBAL DIGITAL HEALTH PORTFOLIO. PATH ALSO LAUNCHED THE CENTER OF DIGITAL AND DATA EXCELLENCE, A BODY DESIGNED TO COORDINATE DIGITAL HEALTH EFFORTS ACROSS PATH. WE CONTINUED WORK UNDER DIGITAL SQUARE, A PATH-LED INITIATIVE. THIS IS A PARTNERSHIP OF THE WORLD'S LEADING DIGITAL HEALTH EXPERTS FROM MORE THAN 40 ORGANIZATIONS AND COUNTRIES WORKING TOGETHER TO STRENGTHEN DIGITAL HEALTH SYSTEMS IN EMERGING ECONOMIES. IN ADDITION, WE COLLABORATED WITH THE JOINT LEARNING NETWORK FOR UNIVERSAL HEALTH COVERAGE TO CONTINUE A PEER LEARNING NETWORK THAT INCLUDES PROFESSIONALS FROM MINISTRIES OF HEALTH AND NATIONAL HEALTH INSURANCE AGENCIES IN TEN COUNTRIES. THESE PROFESSIONALS ARE WORKING TO IMPROVE THEIR HEALTH CARE DATA SYSTEMS, WHICH WILL HELP THEIR COUNTRIES ACHIEVE UNIVERSAL HEALTH COVERAGE. WE CONTINUED IMPLEMENTATION OF THE TANZANIA DATA USE PARTNERSHIP, WHICH SUPPORTS THE GOVERNMENT OF TANZANIA TO IMPROVE COUNTRYWIDE HEALTH INFORMATION SYSTEMS AND IMPLEMENT ITS DIGITAL HEALTH INVESTMENT ROAD MAP. THE BID INITIATIVE, A COLLABORATION BETWEEN PATH AND THE GOVERNMENTS OF TANZANIA AND ZAMBIA, HAS EMPOWERED THESE COUNTRY GOVERNMENTS TO ENHANCE IMMUNIZATION THROUGH IMPROVED DATA COLLECTION, QUALITY, AND USE. THIS PROJECT ENDED IN 2018, AND PROJECT CLOSE-OUT ACTIVITIES INCLUDED THE DOCUMENTATION AND SHARING OF PROJECT LEARNINGS. THE DIGITAL HEALTH TEAM ALSO SUPPORTED THE IMMUNIZATION DATA: EVIDENCE FOR ACTION REVIEW. THIS INITIATIVE REVIEWED AVAILABLE EVIDENCE ON WHAT WORKS TO IMPROVE THE USE OF IMMUNIZATION DATA, SYNTHESIZED THE FINDINGS, AND DISTRIBUTED THE FINDINGS THROUGH AN ADVOCACY AND COMMUNICATIONS CAMPAIGN. COUNTRY PROGRAMS PATH'S COUNTRY PROGRAMS SUPPORT WORK RANGING FROM SMALL-SCALE PILOTS TO LARGE, MULTICOUNTRY EFFORTS. IN 2018, WE OPERATED FULL-SCALE "COUNTRY" OFFICES IN THE DRC, ETHIOPIA, INDIA, KENYA, MYANMAR, SENEGAL, TANZANIA, UGANDA, UKRAINE, VIETNAM, AND ZAMBIA, AS WELL AS SMALLER "PROJECT" OFFICES IN MANY OTHER COUNTRIES. EXAMPLES OF OUR COUNTRY PROGRAM WORK ARE HIGHLIGHTED BELOW, FOCUSING ON THE DRC, KENYA, AND INDIA. IN RESPONSE TO RECURRING EBOLA OUTBREAKS IN THE DRC, PATH HAS FOCUSED ON STRENGTHENING GLOBAL HEALTH SECURITY AND EPIDEMIC PREPAREDNESS IN COLLABORATION WITH THE MINISTRY OF HEALTH (MOH). IN MAY 2018, THE DRC EXPERIENCED ITS SECOND EBOLA OUTBREAK IN LESS THAN 12 MONTHS. IN COLLABORATION WITH THE MOH, PATH DEPLOYED THE FIRST WAVE OF 12 MOH INVESTIGATORS, 10 EPIDEMIOLOGISTS, AND 6 COMMUNICATIONS EXPERTS TO THE CITY OF MBANDAKA TO ASSESS THE OUTBREAK. PATH ALSO ADVISED THE MOH ON IMPLEMENTATION OF A STRATEGY FOR DATA COLLECTION. THIS METHOD USED SATELLITE IMAGERY TO REFINE MAPS SO THE MOH, PATH, AND OTHER KEY PARTNERS COULD BETTER TRACK THE OUTBREAK. UNDER A GLOBAL HEALTH SECURITY EBOLA OUTBREAK RESPONSE GRANT, PATH CONTINUED TO PROVIDE SUPPORT THROUGHOUT THE 2018 OUTBREAK, BUILDING DATA MANAGEMENT AND VISUALIZATION CAPACITY AT THE EMERGENCY OPERATIONS CENTER IN KINSHASA AND COORDINATING WORK ACROSS KEY RESPONDERS, SUCH AS WHO, THE UNITED NATIONS OFFICE FOR THE COORDINATION OF HUMANITARIAN AFFAIRS, AND THE US CENTERS FOR DISEASE CONTROL AND PREVENTION. CONCURRENTLY, PATH CONTINUED TO EXPAND SCREENING FOR HUMAN AFRICAN TRYPANOSOMIASIS (HAT; ALSO CALLED SLEEPING SICKNESS) IN BANDUNDU PROVINCE. IN RECENT YEARS, UP TO 60 TO 80 PERCENT OF ALL CASES WORLDWIDE HAVE BEEN REPORTED FROM THE DRC. RESEARCH HAS SHOWN THAT DISEASE CONTROL HINGES ON ACTIVE POPULATION SCREENING AND VECTOR CONTROL. IN 2018, THIS PROJECT FOCUSED ON EXPANDING ANNUAL SCREENING CAPACITY TO ENSURE THAT AS CASES DECLINE, PEOPLE CONTINUE TO PARTICIPATE IN SCREENINGS. IN PARTNERSHIP WITH PATH AND REGIONAL STAKEHOLDERS, THE MOH ESTABLISHED THE FIRST NATIONAL HAT ELIMINATION DAY ON JANUARY 30, 2018, RE-INVIGORATING LOCAL AUTHORITIES TO ACHIEVE THE GOAL OF ELIMINATION. PATH'S WORK TO IMPROVE HIV/AIDS SERVICE DELIVERY IN THE DRC WAS FIRST CONDUCTED THROUGH THE USAID-FUNDED PROVIC PROJECT AND THEN THROUGH ITS FOLLOW-ON, THE INTEGRATED HIV/AIDS PROJECT IN HAUT-KATANGA AND LUALABA. FROM APRIL 2017 THROUGH JUNE 2018, THE PROJECT TESTED AND INFORMED MORE THAN 286,000 PEOPLE OF THEIR HIV STATUS AND ENROLLED MORE THAN 97 PERCENT OF IDENTIFIED HIV-POSITIVE INDIVIDUALS ON ANTIRETROVIRAL THERAPY. IN KENYA, PATH WORKED TO IMPROVE HIV PREVENTION AND TREATMENT THROUGH A PROJECT CALLED "IMPLEMENTING ASSISTED PARTNER SERVICES SCALE-UP STUDY TO HIV TEST AND TREAT MEN." IN 2018, PROJECT START-UP AND IMPLEMENTATION ACTIVITIES FOCUSED ON ENROLLMENT OF WOMEN AND THEIR MALE SEXUAL CONTACTS IN TWO COUNTIES IN WESTERN KENYA WITH A HIGH HIV BURDEN. WOMEN RECEIVED COUNSELING ON PARTNER NOTIFICATION AND PARTNER ELICITATION CONDUCTED BY THE HIV TESTING SERVICE PROVIDER. ELICITED MALE SEXUAL PARTNERS WERE THEN CONTACTED, NOTIFIED OF THE HIV EXPOSURE, AND OFFERED HIV TESTING. ALL CLIENTS NEWLY IDENTIFIED WERE LINKED TO CARE AND STARTED ON ANTIRETROVIRAL THERAPY. EACH ENROLLED PARTICIPANT WAS FOLLOWED UP PERIODICALLY TO ASSESS HIS OR HER LINKAGE TO CARE, ANTIRETROVIRAL TREATMENT INITIATION, AND VIRAL SUPPRESSION. ALL IDENTIFIED PARTNERS WHO DID NOT HAVE HIV WERE REFERRED FOR PRE-EXPOSURE PROPHYLAXIS TO HELP PREVENT FUTURE INFECTION. PATH ALSO CONTINUED WORK UNDER THE APHIAPLUS PROJECT TO HELP INTEGRATE SERVICE DELIVERY FOR HIV/AIDS AND OTHER HEALTH CONCERNS AND INCREASE THE AVAILABILITY OF SERVICES FOR MARGINALIZED POPULATIONS IN WESTERN KENYA. FROM 2011 THROUGH JUNE 2018, APHIAPLUS AND THE PATH-LED AFYA ZIWANI PROJECT PROVIDED HIV TESTING SERVICES TO MORE THAN 6.7 MILLION INDIVIDUALS IN KENYA, IDENTIFIED MORE THAN 102,600 NEW HIV-POSITIVE INDIVIDUALS, AND SUPPORTED MORE THAN 120,000 PEOPLE LIVING WITH HIV/AIDS ON ANTIRETROVIRAL THERAPY, WITH MORE THAN 80 PERCENT ACHIEVING VIRAL SUPPRESSION. TO STRENGTHEN NEWBORN NUTRITION IN KENYA, PATH IMPLEMENTED A PROJECT CALLED THE "MOTHER-BABY FRIENDLY INITIATIVE-PLUS MODEL FOR HUMAN MILK BANKING." FOR VULNERABLE INFANTS, PATH ADVOCATED FOR A HOLISTIC APPROACH OF BREASTFEEDING PROMOTION AND PROVISION OF SAFE DONOR HUMAN MILK WHEN A MOTHER'S MILK IS NOT AVAILABLE. IN 2018, THE PROJECT WORKED TO ESTABLISH LOCAL OWNERSHIP AND TECHNICAL COMPETENCY IN HUMAN MILK BANKING BY DEVELOPING LEARNING EXCHANGES, CONDUCTING FORMATIVE ASSESSMENTS, AND DEVELOPING A COUNTRY-SPECIFIC STRATEGY FOR HUMAN MILK BANKING. THE PROJECT THEN WORKED TO OPERATIONALIZE THIS STRATEGY TO SET UP A HUMAN MILK BANK FOR LAUNCH IN MARCH 2019. IN INDIA, PATH HAS HELPED TO IMPROVE CHILD NUTRITION THROUGH RICE FORTIFICATION. FOR A DECADE, PATH HAS WORKED CLOSELY WITH INDIAN PARTNERS ON THE FORMULATION OF A FORTIFIED RICE PRODUCT (ULTRA RICE) TO REDUCE THE PREVALENCE OF ANEMIA AND MICRONUTRIENT DEFICIENCIES. IN 2018, PATH WORKED WITH LOCAL PROVIDERS TO BRING FORTIFIED RICE TO SCHOOLCHILDREN ACROSS THE STATE OF GUJARAT. THIS FORTIFIED RICE PROVIDED CHILDREN WITH VITAL MICRONUTRIENTS THAT MAY OTHERWISE BE LACKING IN THEIR DIETS, INCLUDING IRON, FOLIC ACID, VITAMIN A, AND B COMPLEX VITAMINS. IN THE STATE OF UTTAR PRADESH, PATH SUPPORTED LOCAL GOVERNMENT EFFORTS TO ELIMINATE VISCERAL LEISHMANIASIS, ALSO KNOWN AS KALA-AZAR, IN NINE AFFECTED DISTRICTS. KALA-AZAR IS A PARASITIC DISEASE TRANSMITTED BY INFECTED SAND FLIES THAT HAS A HIGH FATALITY RATE WITHOUT PROPER TREATMENT. IN 2018, PATH DEVELOPED TOOLS TO ASSESS THE USE OF PREVENTIVE MEASURES, SUCH AS INDOOR RESIDUAL SPRAYING, AND THE AVAILABILITY
FORM 990, PART III, LINE 4A OF DIAGNOSTIC KITS AND DRUGS TO TREAT THE DISEASE. THE PROJECT ALSO STRENGTHENED THE QUALITY OF SURVEILLANCE SYSTEMS BY BUILDING THE CAPACITY OF LOCAL GOVERNMENT. WE SUPPORTED THE GOVERNMENT TO REGULARLY PERFORM DATA QUALITY CHECKS AND CONDUCT DATA VISUALIZATION TO IDENTIFY NEWLY AFFECTED VILLAGES. THIS ENABLED MORE TIMELY DECISION-MAKING AND ACTIONS ON PREVENTION AND TREATMENT. PATH ALSO CONTINUED INNOVATIVE URBAN TB CONTROL EFFORTS IN INDIA. THE PPIA PROJECT, WORKING TO ENHANCE THE ROLE OF PRIVATE HEALTH CARE PROVIDERS IN TB CONTROL, PROVIDED FREE OR SUBSIDIZED SERVICES TO PATIENTS IN MUMBAI WHO WOULD OTHERWISE BE UNABLE TO AFFORD THIS CARE. FROM THE PROJECT'S LAUNCH THROUGH 2018, 202,468 PRESUMPTIVE TB CASES WERE SCREENED AFTER BEING REFERRED FROM THE PRIVATE SECTOR, AND 62,633 PEOPLE (31 PERCENT) WERE DIAGNOSED AND NOTIFIED. A TOTAL OF 49,856 PATIENTS WERE SUPPORTED FOR TREATMENT ADHERENCE MONITORING, AND 2,790 TB PATIENTS WERE LINKED TO PUBLIC-SECTOR SUPPORT.
FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CHIEF OF ACCOUNTING SIGNED THE FORM.
FORM 990, PART VI, SECTION B, LINE 12C PATH HAS POLICIES AND PROCEDURES TO ADDRESS CONFLICTS OF INTEREST. PATH MANAGEMENT AND ALL STAFF AT A DESIGNATED LEVEL OR HIGHER WITHIN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER, AND THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING.
FORM 990, PART VI, SECTION B, LINE 15 THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARIES AND BENEFITS FOR EXECUTIVE EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE PRESIDENT/CHIEF EXECUTIVE OFFICER (CEO) ON COMPENSATION DECISIONS FOR EXECUTIVE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT/CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS). THE MOST RECENT MAJOR REVIEW WAS COMPLETED BY THE BOARD COMPENSATION COMMITTEE IN 2017. AT THE REQUEST OF THE BOARD, PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE USE OF THE REPORT TO ESTABLISH A FRAMEWORK WITHIN WHICH THE PRESIDENT/CEO IS DELEGATED AUTHORITY TO ESTABLISH THE TOTAL COMPENSATION PACKAGES OF THE VICE PRESIDENTS AND EXECUTIVE TEAM MEMBERS. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFITS PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S TOTAL COMPENSATION PACKAGE.
FORM 990, PART VI, SECTION C, LINE 19 PATH GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.
FORM 990, PART XI, LINE 9: FOR THE YEAR ENDED DECEMBER 31, 2018, THE ORGANIZATION ADOPTED THE FINANCIAL ACCOUNTING STANDARDS BOARD'S ACCOUNTING STANDARDS UPDATE (ASU) NO. 2018-08 - NOT-FOR-PROFIT ENTITIES (TOPIC 958): CLARIFYING THE SCOPE AND THE ACCOUNTING GUIDANCE FOR CONTRIBUTIONS RECEIVED AND CONTRIBUTIONS MADE FOR REVENUE TRANSACTIONS. THE UPDATE ASSISTS ENTITIES IN (1) EVALUATING WHETHER TRANSACTIONS SHOULD BE ACCOUNTED FOR AS CONTRIBUTIONS (NONRECIPROCAL TRANSACTIONS) OR AS EXCHANGE (RECIPROCAL) TRANSACTIONS AND (2) DETERMINING WHETHER A CONTRIBUTION IS CONDITIONAL. THE PRIMARY EFFECT OF ADOPTION OF THIS ASU FOR THE ORGANIZATION IS THAT CERTAIN AWARDS RECEIVED THAT WERE PREVIOUSLY TREATED AS UNCONDITIONAL ARE NOW TREATED AS CONDITIONAL. AS A RESULT, REVENUE FOR THESE AWARDS IS RECOGNIZED WHEN THE CONDITIONS ARE MET DURING THE AWARD TERM, WHEREAS PREVIOUSLY REVENUE HAD BEEN RECOGNIZED WHEN THE AWARDS WERE AWARDED. PATH HAS ELECTED TO ADOPT THE CHANGES FROM THIS ASU RETROSPECTIVELY TO THE 2017 FINANCIAL STATEMENTS. THE NET EFFECT OF THIS CHANGE IS PRESENTED AS AN OTHER CHANGE IN NET ASSETS. -378,755,643.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2018


Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBulletAttach to Form 990.
MediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047
2018
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Identification of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33.
(a)
Name, address, and EIN (if applicable) of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income


 		(e)
End-of-year assets


 		(f)
Direct controlling
entity










Part II
Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section


 		(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled entity?
Yes No
(1)PATH VACCINE SOLUTIONS
2201 WESTLAKE AVENUE

SEATTLE,WA98109
83-0431851 		ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN WA 501(C)(3) LINE 12A, I PATH
 
Yes
 
(2)PATH DRUG SOLUTIONS
280 UTAH AVENUE SUITE 250

SAN FRANCISCO,CA94080
94-3384500 		DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES CA 501(C)(3) LINE 12A, I PATH
 
Yes
 
(3)FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
207 ROUTE DE FERNEY 1218 LE GRAND-S
GENEVA    
SZ
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH SZ 501(C)(3)   PATH
 
Yes
 








For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2018
Schedule R (Form 990) 2018
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V-UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.
(a)
Name, address, and EIN of
related organization
 		(b)
Primary activity
 		(c)
Legal
domicile
(state or foreign
country)
 		(d)
Direct controlling
entity
 		(e)
Type of entity
(C corp, S corp,
or trust) 		(f)
Share of total income
 		(g)
Share of end-of-year
assets
 		(h)
Percentage
ownership
 		(i)
Section 512(b)(13) controlled entity?
Yes No












Schedule R (Form 990) 2018
Schedule R (Form 990) 2018
Page 3
Part V
Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.
Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity .....................
1a
 
No
b Gift, grant, or capital contribution to related organization(s) ............................
1b
Yes
 
c Gift, grant, or capital contribution from related organization(s) ............................
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) ............................
1d
 
No
e Loans or loan guarantees by related organization(s) ............................
1e
 
No
f Dividends from related organization(s) ............................
1f
 
No
g Sale of assets to related organization(s) ............................
1g
 
No
h Purchase of assets from related organization(s) ............................
1h
 
No
i Exchange of assets with related organization(s) ............................
1i
 
No
j Lease of facilities, equipment, or other assets to related organization(s) .......................
1j
 
No
k Lease of facilities, equipment, or other assets from related organization(s) ......................
1k
 
No
l Performance of services or membership or fundraising solicitations for related organization(s) .....................
1l
 
No
m Performance of services or membership or fundraising solicitations by related organization(s) .................
1m
 
No
n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ...................
1n
 
No
o Sharing of paid employees with related organization(s) ............................
1o
 
No
p Reimbursement paid to related organization(s) for expenses ............................
1p
 
No
q Reimbursement paid by related organization(s) for expenses ............................
1q
 
No
r Other transfer of cash or property to related organization(s) ............................
1r
 
No
s Other transfer of cash or property from related organization(s) ............................
1s
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of related organization 		(b)
Transaction
type (a-s) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) PATH VACCINE SOLUTIONS

 C 20,062,779 FMV
(2) PATH DRUG SOLUTIONS

 C 2,964,636 FMV
(3) FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND

 C 520,410 FMV
(4) FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND

 B 3,321,058 FMV


Schedule R (Form 990) 2018
Schedule R (Form 990) 2018
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 37.
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income (related, unrelated, excluded from tax under sections 512-514)

(e)
Are all partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V-UBI
amount in box 20
of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2018
Schedule R (Form 990) 2018
Page 5
Part VII
Supplemental Information
Provide additional information for responses to questions on Schedule R (see instructions).
Return Reference Explanation
Schedule R (Form 990) 2018

Additional Data


Software ID:  
Software Version: